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ABSTRACT 
Molecular Basis for the Recognition of the Regulatory Stem-loop Structures in 
Eukaryotic Messenger RNAs 
Dazhi Tan 
 
Apart from carrying genetic information, RNAs also act as effectors of cellular processes 
through folding into intricate secondary and tertiary structures. The ubiquitous RNA structures in 
eukaryotic mRNAs, in collaboration with specific RNA-binding proteins, control many aspects 
of the post-transcriptional regulation of gene expression. However, the molecular bases for the 
recognition of these mRNA structures by their protein partners remain poorly understood due to 
the lack of structural information.  
This dissertation presents our structural studies on two protein-RNA complexes that both 
include regulatory mRNA stem-loop structures. We first describe the crystal structure of a 
ternary complex including the highly conserved human histone mRNA stem-loop (SL), the stem-
loop binding protein (SLBP) and the 3′ to 5′ exonuclease 3′hExo. This structure identifies a 
single sequence-specific interaction between the SL and SLBP, and the mostly shape-dependent 
RNA-recognition mode by both proteins. In addition to explaining the large body of biochemical 
and biophysical data on this complex accumulated over the last two decades, we also for the first 
time elucidate the induced-fit mechanism underlying the cooperativity between SLBP and 
3′hExo. We next shift our focus to a class of less conserved mRNA stem-loop structures named 
constitutive decay elements (CDE). The RNA-binding ROQ domain of Roquin recognizes the 
various CDEs and mediates the decay of CDE-containing mRNAs, which predominantly encode 
proteins responsible for inflammation and autoimmunity. Structural and biochemical studies of 
the ROQ domain in complex with two different CDE RNAs unexpectedly reveal two distinct 
RNA binding sites on this protein, one recognizing CDE stem-loops and the other binding to 
double-stranded RNAs. The stuctures are also in agreement with the versatility of Roquin and 
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Figure 1. Schematic drawing of several RNA secondary structure elements formed by a single 
strand. The dashed line in the duplex indicates the part of the RNA beyond the base paired 
region, which can adopt any shape. The rhomboids in the G-quadruplex are virtual planes where 
the four guanine bases associate through Hoogsteen base pairing. 
Figure 2. (A) Schematic strategy of the DMS modification method (Rouskin et al., 2013). The 
green spheres indicate sites of DMS modification. Live cells were incubated in the DMS-
containing buffer for the modification to occur. (B) Schematic strategy of the RNase treatment 
method (Kertesz et al., 2010). The mRNA samples were deproteinated prior to RNase digestion. 
Figure 3. Schematic drawing of several strategies employed by mRNA structures to modulate 
splicing. Exons are drawn in red lines while introns are in red. (A) The stem-loop structure 
inhibits splicing through sequestering the 5′ splice site. (B) The RNA duplex promotes splicing 
through bringing together the 5′ and 3′ splice sites in a long intron. The blue square indicates the 
spliceosome. (C) The mRNA structures inside an intron sequester the cryptic splice sites, which 
are shown as red asterisks. (D) The RNA duplex shown in this panel bridges the 5′ splice site of 
Intron 1 and the 3′ splice site of Intron 2, thus promoting the exclusion of Exon 2.  
Figure 4. Schematic drawing of the mechanism for mRNA localization, adapted from (Martin 
and Ephrussi, 2009). The orange shapes within the RNA granule indicate unknown protein 
factors essential for the assembly of the mRNAs. LE, localization element. LBP, LE-binding 
protein.  
Table 1.  Examples of mRNA structures that modulate splicing 
Table 2.  Examples of mRNA structures that control mRNA localization 





Figure 1. Schematic drawing of the level of canonical histone mRNAs during the cell cycle. 
This figure is adapted from (Marzluff et al., 2008). The horizontal axis shows the different 
phases of the cell cycle and does not necessarily represent the actual lengths of these stages. The 
vertical axis is in log scale. 
Figure 2. The processing pathways of polyadenylated mRNAs and canonical histone mRNAs. 
The thin lines represent the untranslated regions while the filled rectangles represent the coding 
regions. The stem-loop structure in the 3′-UTR of canonical histone mRNAs is shown. 
Figure 3. (A) Schematic drawing of the sequence elements and the protein factors involved in 
the 3′-end processing of canonical histone mRNAs. The endonuclease CPSF73 is highlighted, 
with the scissor representing the cleavage site. CPSF, cleavage and polyadenylation specificity 
factor. CstF, cleavage stimulation factor. FLASH, the FLICE-associated-huge-protein, interacts 
with Lsm11 and recruits CPSF73 to the processing complex. (B) The consensus sequence of the 
histone mRNA stem-loop. The numbering scheme of the nucleotides in the SL is also shown. 
Figure 4. Alignment of the sequences of histone pre-mRNAs near the stem-loop. The consensus 
sequence is highlighted in cyan. C. elegans histone mRNAs have a C at the first position of the 
loop (in red), distinct from the others. The cleavage site indicates the end of mature mRNAs 
(Avgousti et al., 2012). The sequences are obtained from (López and Samuelsson, 2008).  
Figure 5. (A) Domain organization and sequence conservation of human SLBP and 3′hExo. The 
upper half of each bargraph shows the domain organization, while the lower half shows sequence 
conservation. The degree of conservation is indicated in color scale. The segment following the 
RBD of SLBP that is dispensable for binding to the SL yet essential for the proper 3′-end 
processing of canonical histone mRNAs is colored in magenta. (Produced with the program 
Bargraf, Tong L., unpublished) (B) Sequence alignment of the RBD (cyan) of SLBP. The 
secondary structure elements based on the structure of the SL-SLBP-3′hExo ternary complex are 
shown. Dashed lines indicate residues that are disordered in the crystal, and dots indicate gaps in 
the alignment. Residues in contact with the SL are marked with the red asterisks. (C) Sequence 
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alignment of 3′hExo. Secondary structure elements in the SAP domain (yellow) and the nuclease 
domain (green) are shown. The four acidic residues that coordinate the metal ions are indicated 
with the red triangles. Residues in contact with the SL are marked with the red asterisks. 
Residues N-terminal of the SAP domain are not shown. 
Figure 6. (A) Crystal structure of the SL-SLBP-3′hExo ternary complex at 2.6 Å (Tan et al., 
2013). Two views related by a 90o rotation around the horizontal axis are shown. The SL is in 
orange, the RBD of SLBP is in cyan, the SAP domain of 3′hExo is in yellow and the nuclease 
domain is in green. Numbering of the secondary structure elements is also shown. The dotted 
lines indicate loops that are disordered. (B) Composite omit Fo-Fc electron density map of the 
SL, contoured at 3σ. (C) Close-up view of the tetraloop. The electron density map is the same as 
in (B). Red dashed lines indicate hydrogen bonds mediating the U11-A16 base pair. (D) Overlay 
of the stem of the SL with A-form RNA. The stem of the SL is in orange while the standard A-
form RNA molecule is in black. Only the backbone atoms were used in the structural alignment, 
which was performed using the program Coot (Emsley and Cowtan, 2004). The structure of A-
form RNA was generated by the program 3DNA (Lu and Olson, 2003).  The structure figures 
were produced with PyMOL (Schrödinger, 2010). 
Figure 7. (A) SLBP is on the same side as the major groove of the SL. The side chain of Arg181 
or SLBP is shown. (B) Interactions between the 5′ flanking sequence of the SL and the N-
terminus of αC of SLBP. Red dashed lines indicate hydrogen bonds. Water molecules are 
represented as red spheres. (C) Arg181 of SLBP specifically recognizes the G7 base of the SL 
through bidentate hydrogen bonds. Simulated annealing Fo-Fc omit electron density contoured at 
5σ is shown. (D) Interactions between the 5′ arm of the stem and SLBP. (E) Protein-RNA 
interactions at the tetraloop of the SL. (F) Interactions between the 3′ arm of the stem and 
3′hExo. (G) Interactions between the 3′ end of the SL and the active site of 3′hExo. The AMP 
molecule (gray) and the two Mg2+ ions (pink spheres) were modeled in using PDB entry 1W0H. 
(H) Electrostatic surface of the active site of 3′hExo. Blue and red regions show positive and 
negative electrostatic potential, respectively. The black arrow points at a channel on the other 
side of the active site that may accommodate longer RNA substrates. 
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Figure 8. Schematic drawing summarizing the protein-RNA interactions in the SL-SLBP-3′hExo 
ternary complex. The interactions involve the side chains of the protein residues unless the main 
chain atoms are otherwise labeled. Water molecules mediating the interactions are also shown. 
Figure 9.   (A) Surface representation of the structures of SLBP RBD and 3′hExo in the ternary 
complex. The red arrow points at the gap between the two proteins. (B) Structure of the entire 
asymmetric unit. The ternary complex is in color and the SL-3′hExo ternary complex is in gray. 
(C) Overlay of the structures of the ternary (color) and binary (gray and black) complexes. The 
red arrow shows the direction of the slight movement of the SAP domain in the binary complex 
compared to that in the ternary complex. (D, E) Overlay of the crystal structure of the SL in the 
ternary complex (orange) and two NMR structures (gray). The rearrangement of the bases in the 
tetraloop is illustrated by the red arrows. 
Figure 10. (A) EMSA result of the SL-SLBP binary complexes. Smears on the gel indicate 
unstable SL-SLBP complexes that disassociated during electrophoresis. The K156A mutation is 
a control. (B) EMSA result of the SL-3′hExo binary complexes. The K300A mutation is a 
control. (C) EMSA result of the SL-SLBP-3′hExo ternary complexes with WT 3′hExo and WT 
or mutant SLBP. 
Figure 11. (A) Overlay of the crystal structures of the SL-SLBP (pT171)-3′hExo ternary 
complex (color) and the SL-SLBP-3′hExo ternary complex (gray). The side chain of the pThr171 
residue is shown. The red arrow points to the segment in the αB-αC loop of the RBD that is 
disordered in the structure of the unphosphorylated ternary complex. (B) Interactions involving 
the phosphate group on pThr171. Hydrogen bonds and salt bridges are shown with red dashed 
lines. The red sphere is a water molecule that mediates the interaction between Trp190 and the 
phosphate group. Simulated-annealing omit Fo-Fc electron density for the phosphate is also 
shown, contoured at 3σ. The pink shaded area indicates a surface on SLBP that may mediate 
interactions with other protein factors essential for histone mRNA 3’-end processing. 
Table 1. Data collection and refinement statistics of the SL-SLBP-3′hExo ternary 
complex 
Table 2.  Helical parameters for the stem of the SL 
! ix 
Table 3. Data collection and refinement statistics of the SL-SLBP (pT171) -3′hExo 
ternary complex 
Table 4. Structural interpretation of observations on SLBP and 3′hExo mutants 
reported earlier 
Table 5. Structural interpretation of observations on SL mutants reported earlier 
 
Chapter III 
Figure 1. (A) Sequences of CDE stem-loops of a number of human genes. ICOS, inducible T-
cell co-stimulator. Ier3, immediate early response 3. Bmpr1a, bone morphogenetic protein 
receptor, type IA. Hmgxb3, HMG box domain containing 3. NFκBiz, nuclear factor of kappa 
light polypeptide gene enhancer in B cells inhibitor, zeta. Ppp1r10, protein phosphatase 1, 
regulatory subunit 10. CSF-3, colony stimulating factor 3 (granulocyte). (B) Schematic drawing 
of the mechanism of CDE-mediated mRNA decay.  
Figure 2.  (A) Domain organization and sequence conservation of human Roquin. The upper 
half of each bargraph shows the domain organization, while the lower half shows sequence 
conservation. The degree of conservation is indicated in color scale. CC, coiled-coil. (B) 
Sequence alignment of the N-terminal domains of Roquin and Roquin-2. Hs, Homo sapiens. Rn, 
Rattus norvegicus. Dr, Danio rerio. R1, Roquin. R2, Roquin-2. 
Figure 3. (A) Schematic drawing of the TNF23 stem-loop. The numbering scheme used in this 
chapter is also indicated. (B) Crystal structure of the ROQ-TNF23 complex at 1.9 Å resolution. 
Two views related by a 90o rotation around the vertical axis are shown. TNF23 RNA is in orange, 
while the three subdomains of the ROQ domain are colored in yellow, cyan, green, respectively. 
The side chain of the M199 residue is in stick representation, with the carbon atoms colored in 
red. Numbering of the secondary structure elements is also shown. (C) Overlay of the structures 
of domain III of ROQ domain (green) and the WH-B domain of cullin 1 (gray). (D) Overlay of 
the structures of the two ROQ-TNF23 complexes in the asymmetric unit. The structure in color 
has part of the β-sheet disordered, while the αA-αB loop in the gray structure is disordered. The 
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structural overlay is based on Cα atoms. (E) Electrostatic surface of the TNF23 binding site. 
Negatively charged residues are colored red while positively charged residues are colored blue. 
All the structure figures were produced with PyMOL (Schrödinger, 2010). 
Figure 4. (A) Composite omit electron density of the TNF23 duplex, contoured at 3σ. The red 
arrow points to the disordered U10 base in one strand. (B) Schematic drawing of the TNF23 
duplex. (C) The structure of the TNF23 duplex in complex with two ROQ domains in one 
asymmetric unit. One ROQ monomer is in color and the other in gray. There is no contact 
between the ROQ domain and the nucleotides in the center of the duplex, which correspond to 
the loop in the stem-loop conformation. (D) Gel-filtration profiles the ROQ-TNF23 complexes 
prepared under different conditions. The absorption of UV at 260 nM wavelength is plotted. The 
gray dashed lines indicate the elution volumes of the ROQ domain and the dimeric ROQ-TNF23 
complex, respectively. The ROQ-TNF23 complex in the bottom panel is primarily in the 
monomeric form. 
Figure 5. (A) Overview the TNF23 binding site. Only the ROQ-TNF23 complex where the U1 
base flips out is shown here. (B) Interactions between the 5′ arm of TNF23 and subdomain II of 
the ROQ domain. Hydrogen bonds are indicated as red dashed lines. Water molecules are shown 
as red spheres. (C) Interactions between the 3′ arm of TNF23 and subdomain I of the ROQ 
domain. (D) Overlay of the two halves of the TNF23 duplex. The part of the duplex where U1 
flips out is in orange, while the other part is in gray. (E) Interactions of Arg131 with nucleotides 
near the end of the duplex in the ROQ-TNF23 complex where U1 flips out. (F) Interactions of 
Arg131 with the G17 base in the ROQ-TNF23 complex (gray) where U1 and A–1 are disordered. 
The G17 base from the other complex is also shown (in orange). The red arrow indicates the 
change in the position of this base in the two complexes. 
Figure 6. (A) Schematic drawing of the Hmg19 RNA stem-loop. The numbering scheme used in 
this chapter is also indicated. (B) Composite omit electron density map of the Hmg19 RNA, 
contoured at 3σ level. (C) Crystal structure of the ROQ-Hmg19 complex at 2.9 Å resolution. Two 
views related by a 90o rotation around the vertical axis are shown. Hmg19 RNA is in orange. The 
side chain of the M199 residue is in stick representation, with the carbon atoms colored in red.  
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Figure 7. (A) Interactions between the triloop of Hmg19 and the ROQ domain. Red dashed lines 
indicate hydrogen bonds. (B) Interactions between the 5′ arm of Hmg19 and the ROQ domain. 
(C) Electrostatic surface of the Hmg19 binding site. Negatively charged residues are colored red 
while positively charged residues are colored blue. (D) Overlay of the structures of domain III of 
ROQ domain (green) and the WH motif of elongation factor SelB in complex with SECIS RNA 
(gray). 
Figure 8.   (A) Overlay of the structures of the ROQ-Hmg19 complex (color) and the ROQ-
TNF23 complex (gray). The 30o rotation of domain I relative to domains II and III is shown. The 
red square circles the β2-β3 loop in domain III that are shifted slightly between the two 
structures. (B) Overlay of the structures of domain III (green) in complex with Hmg19 (orange) 
and domain II (cyan) in complex with TNF23 (yellow). Helix αD of domain II is not shown here. 
Only the backbones of the RNA molecules are shown. (C) Overlay of the structures of Hmg19 
(orange) and TNF23 (black) in the two complexes. Only the half of the TNF23 duplex where U1 
flips out is shown here. 
Figure 9.   (A) Structure of the ROQ-Hmg19 complex in the neighborhood of the Met199 
residue. The red dashed line shows the shortest distance between Met199 and the Hmg19 RNA. 
(B) Surface representation of domain III in the view of Figure 9A. The red and yellow patches 
represent the solvent-accessible surface of the side chain of Met199.  
Figure 10.   (A) Schematic drawing of the RNAs used for EMSAs. (B) EMSA with the WT and 
the mutant ROQ proteins under 200 mM NaCl. The slow-moving bands that represent the 
protein-RNA complexes run at different rates on the gel due to the altered electrostatic properties 
of the complexes caused by the mutations. (C) EMSA with the WT and the mutant ROQ proteins 
under 50 mM NaCl. The RNAs and proteins in all of the samples were under 1 µM 
concentration.  
Figure 11.  (A) EMSA with WT ROQ, labeled TNF23, and unlabeled Hmg19. The concentrations 
of each molecule in each sample are indicated. (B) EMSA with an A site ROQ mutant, labeled 
TNF23, and unlabeled Hmg19. All the EMSA samples were mixed in a buffer containing 50 mM 
! xii 
NaCl.  
Figure 12. (A) EMSA with the Hmg19 or TNF23 stem-loop RNAs and decreasing amount of WT 
ROQ. Only bands representing the ROQ-RNA (1:1) complexes are present. (B) Schematic 
drawing of the longer stem-loop RNAs. (C) EMSA with the longer stem-loop RNAs and 
decreasing amount of WT ROQ. (D) EMSA with an A site mutant of ROQ and increasing 
amount of the longer stem-loop RNAs. The slow-moving faint bands represent the weak ROQ-
RNA complexes mediated by the A site. (E) EMSA with the 5′ arm of TNFds and WT ROQ. (F) 
EMSA with a double-stranded DNA molecule and the WT and mutant ROQ proteins. The DNA 
bands were visualized by ethidium bromide instead of fluorescent labels. All the EMSA samples 
were mixed in a buffer containing 50 mM NaCl.  
Figure 13. (A) Possible linkages between the RNA molecules in the B site and A site. A single-
stranded RNA (gray, 7 nts) was modeled to connect the 3′-end of the RNA in the B site to the 5′ 
end of the stem-loop RNA in the A site (~30 Å distance). A linker between the 3′ end of the 
RNA in the A site to the 5′ end of the RNA in the B site would need to span ~60 Å (gray dots). 
(B) Schematic drawing of the model in (A).  
Figure 14. A model for the binding of double-stranded RNAs to the B site. Two views of the 
ROQ domain are shown here. The coloring scheme is the same as Figure 3. 
Table 1. Data collection and refinement statistics of the ROQ-TNF23 complex 
Table 2. Data collection and refinement statistics of the ROQ-Hmg19 complex 
Table 3. Helical parameters of the base-paired regions of the TNF23 duplex 
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Chapter I 
Eukaryotic mRNA structures play pivotal roles in post-
transcriptional regulation of gene expression 
 
1.1 A brief introduction to regulatory mRNA structures 
RNA is unique among biological macromolecules in that it acts as an informational 
molecule as well as an effector of cellular processes, with the latter duty achieved by its 
capability of folding into intricate secondary and tertiary structures. Ribosomal RNAs (rRNAs) 
and transfer RNAs (tRNAs) are well-known examples of RNAs whose biological functions 
depend upon their three-dimensional conformations. Over the last decade, it has been appreciated 
that messenger RNAs (mRNAs) also contain cis-elements that can fold into unique structures 
and control many aspects of the post-transcriptional regulation of gene expression (1). The most 
studied mRNA structures are the riboswitches, which primarily exist in bacteria with a few found 
in yeast, algae and plants. The excellent review by R. R. Breaker (2) comprehensively elaborated 
the current knowledge on the structures, functions and evolution of riboswitches, which can 
regulate the transcription, processing and translation of the downstream mRNAs through sensing 
cellular stimuli such as temperature, metal ions, and small organic compounds in the absence of 
protein factors (3–5). In most eukaryotes, however, mRNA structures are more prone to 
performing their functions in collaboration with specific RNA-binding proteins.  
Like protein structures, RNA structures can also be described at four levels. The primary 
structure denotes the linear sequence of an RNA molecule, the conformation of a single 
nucleotide as well as the manners in which nucleotides are linked by phosphodiester bonds. RNA 
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secondary structures are primarily formed locally by base pairing between nearby nucleotides. 
Common RNA secondary structure elements include duplex, stem-loop (or hairpin), pseudoknot, 
G-quadruplex, etc. (6–8) (Figure 1). RNA tertiary structure involves multiple secondary structure 
elements that can be rather distant from each other in primary sequence (9). These elements are 
associated through van der Waals interactions as well as additional base pairs between the single-
stranded loops or bulges. The quaternary structure of RNAs generally refers to the interactions 
between individual RNA subunits within large RNP assemblies such as ribosomes and 
spliceosomes.  
 
Figure 1. Schematic drawing of several RNA secondary structure elements formed by a single 
strand. The dashed line in the duplex indicates the part of the RNA beyond the base paired 
region, which can adopt any shape. The rhomboids in the G-quadruplex are virtual planes where 
the four guanine bases associate through Hoogsteen base pairing. 
Given the difficulties in the detection of mRNA structures at their native states, 
computational approaches to predict mRNA structures (mostly secondary structures) based on 
the primary sequences have been developed. These approaches mainly employ two strategies: 
comparative sequence analysis and thermodynamic modeling. The comparative sequence 
analysis strategy is based on the hypothesis that functional mRNA structures are conserved 
through evolution. This method determines secondary structures by pairing genomic loci where 
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variations in one sequence are accompanied by compensatory mutations in the other (10, 11). 
The thermodynamic modeling strategy does not require multi-sequence alignment and seeks to 
fold a single mRNA sequence on the basis of free-energy minimization (12). This approach 
utilizes experimentally derived energy parameters to scan all possible secondary-structure 
configurations and identify the most thermodynamically stable one (13). More accurate 
prediction can be achieved through the combination of both strategies as well as the 
incorporation of restraints obtained from experimental data (14, 15).  
Despite the recent progress in the computational prediction of mRNA structures, several 
major challenges remain. The accuracy of prediction drops drastically when the sequence is 
longer than 700bp (1),  making it quite difficult to predict long-range tertiary structures and 
nearly impossible to obtain the genome-wide landscape of mRNA structures. Moreover, mRNA 
structures are highly dynamic in vivo and are constantly re-organized, whereas in silico 
prediction is incapable of identifying transient mRNA structures. Therefore, the rigorous 
understanding of the mRNA structurome requires in vivo detection of mRNA structures at the 
genomic level, which has become possible thanks to the recent advancement in next-generation 
sequencing.  
There are two approaches to probe mRNA structures in vivo: chemical modification and 
RNase treatment. The chemical modification method uses dimethyl sulphate (DMS) to label 
unpaired adenine and cytosine residues where the reverse transcriptase will stall during RT-PCR. 
Deep-sequencing of the resultant cDNAs will reveal the precise sites of DMS modification, and 
the number of reads at each site is negatively correlated with the likelihood that the base is 
involved in RNA secondary structure (16, 17) (Figure 2A). The RNase treatment method utilizes 
the different substrate preferences of RNase V1 and RNase S1, which cut the RNA at double-
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stranded and single-stranded regions respectively. The mRNA samples treated with either RNase 
V1 or S1 are then deep-sequenced and the V1/S1 digestion profiles of each mapped mRNA 
sequence can be established. The parallel analysis of RNA structure (PARS) score of each 
nucleotide, which equals log2
!"!!"#$%
!"!!"#$% , is hence positively correlated with the probability that 
the nucleotide is base paired in vivo (18, 19) (Figure 2B). DMS modification can occur in live 
cells before preparing the mRNA sample, while RNase treatment requires the extraction and 
deproteination of total cellular mRNA prior to digestion. Consequently, the results of in vivo 
genome-wide mRNA structure probing by the DMS modification method can reflect the native 
state of the mRNA structurome more faithfully. 
 
Figure 2. (A) Schematic strategy of the DMS modification method (16). The green spheres 
indicate sites of DMS modification. Live cells were incubated in the DMS-containing buffer for 
the modification to occur. (B) Schematic strategy of the RNase treatment method (18). The 
mRNA samples were deproteinated prior to RNase digestion. 
Several recent studies on in vivo genome-wide mRNA structure probing underscore the 
dynamics and complexity of the mRNA structurome. Rouskin et al. used the DMS modification 
approach to investigate the discrepancies between the in vivo and in vitro mRNA structures in 
yeast (16). Their main discovery is that there are much fewer structured mRNA regions in vivo 
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than in vitro, and even thermodynamically stable mRNA structures often undergo active 
unfolding in cells. The inherent dynamics of mRNA structures is also appreciated by Ding et 
al.’s finding that mRNAs from genes annotated for stress responses tend to form less stable 
transient structures (17), in agreement with their propensity to undergo conformational changes 
in response to environmental conditions. The biological significance of mRNA structures is 
further accentuated by Wan et al.’s study on the mRNA structuromes of a family trio, which 
reveals that approximately 15% of all transcribed single-nucleotide polymorphisms (SNPs) result 
in altered mRNA structures (19). These three genome-wide in vivo studies, together with the 
numerous previous reports on individual mRNA secondary structure elements, highlight the 
ubiquity as well as the biological significance of mRNA structures. In the following sections, we 
will discuss the roles played by eukaryotic regulatory mRNA structures in the processing, 
localization, translation and degradation of mRNAs. 
 
1.2 mRNA structures modulate pre-mRNA processing 
The processing of most eukaryotic pre-mRNAs involves capping at the 5′-end, splicing in 
the middle, and the coupled endonucleolytic cleavage/polyadenylation reactions at the 3′-end. 
Splicing is heavily affected by mRNA structures. Well-known examples include the Group I/II 
introns, which are essentially self-splicing ribozymes with intricate 3-dimensional structures 
formed by intronic sequences (20, 21). Apart from performing enzymatic activities, mRNA 
structures can also modulate splicing efficiency and control alternative splicing.  
Alternative splicing occurs when the spliceosome chooses different subsets of splice sites 
and joins the corresponding exons together. Whether or not an exon is selected depends upon 
many factors, such as the sequences of the cis-elements recognized by the spliceosome (the 5′ 
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splice site, the branch point, the polypyrimidine tract and the 3′ splice site), the exonic and 
intronic enhancers and silencers that recruit splicing modulator proteins, as well as mRNA 
structure elements (22–24). Some mRNA structures can inhibit splicing through sequestering 
sequence elements that are recognized by the spliceosome (Figure 3A). For instance, in the pre-
mRNA of survival motor neuron 2 (SMN2) gene, a stem-loop structure encompassing the 5′ 
splice site at the junction between Exon 7 and Intron 7 strongly inhibits the binding of the U1 
snRNA, leading to the skipping of exon 7 (25). Similar inhibitory mRNA structures were widely 
observed around the 5′ splice sites of under-spliced introns by in vivo genome-wide mRNA 
structure probing (17). On the other hand, mRNA structures can also shorten the distance 
between the 5′ and 3′ splice sites in long introns, thus stimulating splicing (Figure 3B). One such 
example can be found in the yeast rp51B pre-mRNA whose 315-nt Intron 1 contains a double-
stranded structure, which helps put the 5′ and 3′ splice sites in proximity of each other (26). 
mRNA structures can also enhance the efficiency and specificity of splicing at certain exon-
intron junction by displaying the main splice site while masking the neighboring cryptic sites 
(Figure 3C) (27). Finally, inter-intronic long-range mRNA structures can result in the “looping-
out” of the exons in between, hence providing a mechanism for the alternative exclusion of these 
exons (Figure 3D) (28).  
The mRNA structures that regulate splicing are not static, and are subject to further 
modulation by protein factors that specifically recognize them. Certain RNA-binding proteins 
can lower the efficiency of splicing by stabilizing inhibitory mRNAs structures. For example, the 
muscleblind-like 1 protein (MBNL1) binds to a stem-loop structure that sequesters the 
polypyrimidine tract upstream of Exon 5 of the pre-mRNA of cardiac troponin T (cTNT), 
preventing the binding of U2AF65 and leading to the exclusion of Exon 5 (29). Conversely, 
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protein factors that destabilize inhibitory mRNA structures, mostly helicases, are able to enhance 
splicing. RNA helicase p68 promotes the inclusion of Exon 10 in the pre-mRNA of microtubule-
associated protein tau through resolving an RNA hairpin in the intron to expose the 5′ splice site 
(30). Furthermore, some proteins modulate alternative splicing by stabilizing the mRNA 
duplexes that “loop-out” certain exons (Figure 3D), such as the polypyrimidine-tract binding 
protein (PTB) which represses the inclusion of the N1 exon of c-src transcript (31, 32) . Table 1 




Figure 3. Schematic drawing of several strategies employed by mRNA structures to modulate 
splicing. Exons are drawn in red lines while introns are in black. (A) The stem-loop structure 
inhibits splicing through sequestering the 5′ splice site. (B) The RNA duplex promotes splicing 
through bringing together the 5′ and 3′ splice sites in a long intron. The blue square indicates the 
spliceosome. (C) The mRNA structures inside an intron sequester the cryptic splice sites, which 
are shown as black asterisks. (D) The RNA duplex shown in this panel bridges the 5′ splice site 
of Intron 1 and the 3′ splice site of Intron 2, thus promoting the exclusion of Exon 2.  
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Table 1.  Examples of pre-mRNA structures that modulate splicing 
 
Examples Protein Partner Mechanism Refs. 
human cTNT MBNL1 MBNL1 stabilizes a stem-loop that masks the py1-tract of Intron 4.  (29) 
human Tau p68 Helicase p68 resolves a stem-loop in Intron 10, exposing the 5′ ss2. (30) 
human CD44 p72 Helicase p72 resolves a stem-loop in Intron 4, exposing the 5′ ss. (33) 
human  
CD59, XBP1 IRE1α 
A stem-loop structure at the exon-intron junction is recognized and spliced 
by the RNase IRE1α.  (34) 
human c-src PTB PTB represses the inclusion of Exon N1 through stabilizing a duplex that promotes the “looping-out” of Exon N1. (31, 32) 




hnRNP A1 protein represses the inclusion of Exon 7B of its own mRNA 
through binding to an RNA duplex that promotes the “looping-out” of 
Exon 7B. 
(28) 
yeast RPL30 RPL30 RPL30 regulates the splicing of its own mRNA by stabilizing a stem-loop that buries the 5′ ss. (35) 
human SMN2  A stem-loop sequesters the 5′ ss
 of Intron 7, leading to the exclusion of 
Exon 7. (25) 
human 
presenilin 2  
A stem-loop in Exon 5 represses its inclusion.  (36) 
rat calcitonin  A stem-loop sequesters a sub-optimal 3′ ss, leading to the exclusion of Exon 4. (37) 
fruit fly 
14-3-3ξ, Dscam  
Base pairing between different introns leads to mutually exclusive 
splicing. (38) 
yeast RP51B  An intronic stem-loop enhances splicing through bringing the 5′ ss and 3′ ss to the proximity of each other. (26, 39) 
yeast ACT  A stem-loop in Intron 1 brings together the 5′ and 3′ splice sites as well as buries a cryptic 3′ ss. (40) 
1. py, pyrimidine 
2. ss, splice site 
In addition to controlling the splicing event, RNA structures also play crucial roles in the 
3′-end processing of pre-mRNAs. The signature stem-loop structures in the 3′-UTR of canonical 
histone pre-mRNAs are central to their unique non-polyadenylated 3′-end processing (41, 42, 
Chapter II). Moreover, RNA hairpins as well as G-quadruplexes have been predicted near the 
poly(A) signals of some polyadenylated mRNAs and may be important for maintaining the 
efficiency of the cleavage reaction (43, 44). Bioinformatics studies also identified long mRNA 
structures in the vicinity of the poly(A) signals of Arabidopsis mRNAs. The efficiency of 
polyadenylation is drastically lowered when such structures are altered, suggesting that mRNA 
structures may modulate alternative polyadenylation (45). The ubiquitous existence of such 
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mRNA structures were further confirmed by the in vivo genome-wide mRNA structure probing 
(17). It remains to be investigated how mRNA structures communicate with the cleavage and 
polyadenylation factors to regulate 3′-end processing. 
 
1.3 mRNA structures direct mRNA localization 
After pre-mRNA processing, mature eukaryotic mRNAs are transported from the nucleus 
into the cytoplasm through the nuclear pore complex. The spatial distribution of mRNAs in the 
cytoplasm, however, is far from being random. Most transcripts are localized to well-defined 
subcellular compartments, where they are instantaneously translated or simply deposited for 
future use (46). The best example to substantiate the biological significance of mRNA 
localization probably is the oocyte of fruit fly, in which the polarized distribution of maternal 
mRNAs such as bicoid and nanos directs the proper spatial patterning of early embryonic 
development (47). Specifically localized mRNAs are also crucial for somatic cells to perform 
their functions. For instance, mRNAs of the microtubule-associated protein (MAP), which is 
necessary for the formation and dynamics of dendrites, accumulate in the dendritic cytoplasm of 
oligodendrocytes while being scarce in the cell body (48).  The specific spatial distribution of 
mRNAs directs the synthesis of proteins to occur in the vicinity of their sites of action, thus 
enhancing the efficiency of gene expression. It can also confine toxic proteins within certain 
compartments, staving off the deleterious effects they may exert on the rest of the cell (49). 
The task of transporting mature mRNAs along the cytoskeleton to discrete intracellular 
sites is fulfilled synergistically by three parties: the cis-acting localization elements (LE) in the 
mRNAs, the trans-acting LE-binding proteins, and the cellular motor proteins (50). The LEs, 
also called zipcodes, are usually located in the 3′-UTR. The lengths of LEs may range from 
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several to hundreds of nucleotides. LEs are prone to forming conserved RNA secondary 
structures (51), which are more important than the primary sequences for mRNA localization. 
For example, the proper delivery of the yeast ASH1 mRNA to the bud tip is disrupted by 
mutations that alter the stem-loops formed by its four LEs in the 3′-UTR, while complementary 
mutations that restore the secondary structures can rescue aberrant mRNA localization (52, 53). 
Moreover, some mRNAs may possess multiple clustered LEs with similar secondary structures, 
probably in order to promote LE-recognition through creating a higher local concentration of 
LE-binding proteins (54). 
Some LE-binding proteins indiscriminately bind to the double-stranded regions of the 
mRNA structures, and the specificity of LE-recognition is achieved by the simultaneous binding 
of different proteins. One case to exemplify this point is the synergistic binding of Staufen and 
multiple subunits in the ESCRT-II complex to the LEs of bicoid mRNAs, which are transported 
to the anterior pole of oocytes (55). In contrast, the human fragile X mental retardation protein 
(FMRP) specifically interacts with the G-quadruplex in the LE of the MAP1b mRNA through its 
Arg-Gly-Gly RNA-binding domain, leading to the translocation of the mRNA to the dendritic 
region of neurons (56, 57).  
The mRNPs comprised of mRNAs and the corresponding LE-binding proteins usually 
associate to form large RNA granules prior to being loaded onto cellular motors such as kinesin, 
dynein and myosin (Figure 4) (58–60). We now know that the polypyrimidine tract binding 
protein (PTB) (also discussed in section 1.2) mediates the oligomerization of the oskar mRNPs 
in fruit fly oocytes (61). Nonetheless, the underlying mechanisms for the assembly of other LE-
containing mRNAs are still unclear. Examples of mRNA structures necessary for mRNA 
localization are summarized in Table 2. 
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Figure 4. Schematic drawing of the mechanism for mRNA localization, adapted from (49). The 
orange shapes within the RNA granule indicate unknown protein factors essential for the 
assembly of the mRNA granules. LE, localization element. LBP, LE-binding protein.  
 
Table 2.  Examples of mRNA structures that control mRNA localization 
 
Examples LE mRNA structure 
LE-binding 
protein(s) Biological Significance Refs. 
yeast ASH1 Multiple stem-loops She2p Mating type switching (52, 53) 
yeast Hac1 Long stem-loop ? Stress response (62) 
fruit fly bicoid Multiple stem-loops 
Staufen, subunits of 
the ESCRT-II 
complex 
Embryonic development (63, 64) 
fruit fly oskar Stem-loop Staufen,  hnRNP A/B Embryonic development (65, 66) 
fruit fly fs(1)K10 Duplex ? Embryonic development (67) 
human β-actin Stem-loop ZBP1, ZBP2 Localized expression at the lamellipodia of fibroblasts (68) 
human myelin 
basic protein  Multiple stem-loops hnRNP A2 Myelin membrane morphology (69) 
human MAP1b, 
PSD95, FMRP  G-quadruplex FMRP Dendrite formation (56, 57, 70) 
human CamKIIα G-quadruplex FMRP, hnRNP U, Staufen, etc. Memory formation (71–73) 
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1.4 mRNA structures regulate translation 
The translation of eukaryotic mRNAs involves three steps: initiation, elongation and 
termination (reviewed in (74)). The initiation step generally commences with the eukaryotic 
initiation factors (eIFs) recognizing the 5′ 7-methylguanylate cap of a mature mRNA with the 
assistance of the 3′ polyadenylate tail, leading to the assembly of the 48S initiation complex that 
includes the 40S ribosomal subunit. The initiation complex then scans the mRNA template in a 
5′ to 3′ manner for the AUG start codon, where the 40S subunit stalls, the eIFs dissociate and the 
60S ribosomal subunit joins in to form the complete 80S ribosome. The elongation stage ensues 
with the ribosome propagating along the template until a stop codon is encountered, then the 
translational machinery dissembles and the mRNA is released (74–76).  
Initiation is the rate-limiting step of translation. Stem-loops and G-quadruplexes in the 5′-
UTR of mRNAs can suppress translational initiation by interfering with the recruitment of the 
initiation complex to the mRNA template (Table 3) (77–80). The inhibitory effect of an mRNA 
structure is positively correlated with its proximity to the 5′ cap as well as its thermodynamic 
stability (81, 82). Moreover, overexpression of initiation factor eIF4A, which is an RNA 
helicase, can substantially relieve the inhibition (83). In vitro and in vivo genome-wide mRNA 
structure probing also revealed that mRNAs of high translation rates have significantly lower 
numbers of mRNA structures in the 5′-UTR (17, 18). Apart from acting alone, some 5′-UTR 
mRNA structures can also hinder translational initiation in conjunction with RNA-binding 
proteins, such as the GC-rich 5′-UTR stem-loops in the human TGFβ1 mRNA that are associated 
with the Y box binding protein (YBX1) (84). Nevertheless, not all 5′-UTR mRNA structures are 
translation repressors. The stem-loop structure 75-nt downstream of the 5′ cap of the mRNA 
encoding type I collagen is essential for efficient translation, and mutations that disrupt the 
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hairpin result in 50% lower expression level (85).  
mRNA structures outside the 5′-UTR also play important roles in regulating translation. 
The highly conserved stem-loop in the 3′-UTR of canonical histone mRNAs can stimulate 
translation through recruiting the stem-loop binding protein (SLBP) and the SLBP-interacting 
protein 1(SLIP1), with the latter contacting eIF4E and the 5′ cap (41, 86, Chapter II). In addition, 
the translation of proteins involved in the IFN-γ-induced inflammation pathways such as 
ceruloplasmin and VEGF-A is controlled by conserved stem-loop structures in the 3′-UTR of 
corresponding mRNAs named GAIT elements (87–89).  
Although most translational initiation events depend on the 5′ cap of the mRNA, some 
viral and eukaryotic mRNAs are able to recruit the ribosomes to the internal ribosomal entry 
sites (IRES) in the absence of the cap (90). Translation initiation via IRES is appreciably 
elevated under stress conditions such as hypoxia, heat shock and viral infection, when canonical 
cap-dependent initiation is mostly shut-down (90, 91). IRES elements are generally upstream of 
the start codon and fold into complicated structures, mostly long stem-loops and pseudoknots. 
Some viral IRES elements can bind to the ribosome directly, yet most eukaryotic IRES elements 
require the IRES trans-acting factors (ITAFs) to efficiently recruit the initiation complex. It 
should be noted that ITAFs include multiple hnRNPs as well as the poly-pyrimidine tract binding 
protein (PTB), which are also important for mRNA processing and localization (90, sections 1.2 
and 1.3). 
The elongation step was long assumed to be an uninterrupted event with the ribosomes 
proceeding smoothly on the featureless coding regions of mRNAs. However, the last decade has 
seen the revelation that the coding regions possess complex mRNA structures that control the 
speed of elongation. Single-molecule studies demonstrate that elongation occurs through 
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successive translocation-pause cycles (92). The ribosome will stall whenever it encounters an 
RNA stem-loop, and the duration of the pause is proportional to the stability of the secondary 
structure. Therefore, the efficiency of translation can be modulated through altering the 
landscape of mRNA structures within the CDS. One such example comes from the SNP analysis 
of the human catechol-O-methyltransferase (COMT) gene, which shows that SNPs destabilizing 
the secondary structures in the coding region of the COMT mRNA can dramatically elevate the 
level of the COMT protein, leading to increased pain sensitivity (93–95). In addition to 
controlling translational efficiency, RNA structures in the CDS may also be crucial for the co-
translational folding of multi-domain proteins. Detection of secondary structures in the HIV-1 
genomic RNA with the SHAPE-seq method (a method to detect RNA structures using chemical 
modification which is similar to the DMS-modification method discussed above) illustrates that 
mRNA sequences encoding inter-domain linkers tend to form strong secondary structures (96, 
97).  These mRNA structures will probably force the ribosome to pause on the template for long 
enough time for the proper folding of individual domains.  
Another elongation event controlled by mRNA structures is the programmed ribosomal 
frameshifting (PRF). Stable mRNA secondary structures such as pseudoknots downstream of the 
ribosome can compel it to pause at the “slippery sequences” (mRNA sequences, mostly 
UUUAAAC, that result in irregular ribosomal translocations of two or four nucleotides instead 
of three, leading to frameshift.) (98, 99). Proteins synthesized through PRF either contain 
different downstream sequences that perform distinct functions, as in the case of the mouse Edr 
gene (100), or are pre-terminated, as in the case of mammalian ornithine decarboxylase antizyme 
gene (101).  
More recently, a triplet periodicity of the mRNA structural landscape in the coding 
! 15 
regions was detected by in vitro and in vivo genome-wide mRNA structure probing in yeast, 
Arabidopsis, and human (17–19). This periodic pattern illustrates that the first nucleotide of each 
codon is least likely to be involved in secondary structure while the second nucleotide is most 
structured. These findings are in accordance with the result of an earlier report on genome-wide 
ribosome profiling with single-nucleotide resolution, which shows that the ribosome footprint 
also displays a strong 3-nt periodicity (102). Some speculated that this pattern of mRNA 
structure might be related to the evolution of codon usage, however, its exact biological 
significance of is yet to be appreciated (103).  
Table 3.  Examples of mRNA structures that regulate translation 
 
Examples mRNA structure Effects Refs. 
human collagen 5′-UTR  stem-loop Promotes translation (85) 
vertebrate amyloid 






Recognized by IRE/iron regulatory proteins 
(IRPs), represses translation initiation (104–108) 
human TGFβ1 5′-UTR  stem-loop 
Recognized by YBX1, represses translation 
initiation (84) 
human BCL2, ERA, TRF2 5′-UTR  G-quadruplex Inhibits translation initiation (78–80) 
human histone mRNAs 3′-UTR  stem-loop 
Promotes translation initiation in collaboration 





Bound to GAIT proteins and represses translation 
initiation (87–89) 
human c-myc, Apaf-1, 




IRES element, promotes alternative initiation (109–112) 
yeast ASH1,  
human COMT 
CDS  
stem-loop Inhibits translation elongation 
(52, 53) (93–
95) 
HIV-1 genomic RNA CDS  stem-loop Pauses the elongation complex (96, 97) 
mouse edr, human 
antizyme genes 
CDS 
pseudoknot Induces programmed ribosomal frameshifting (100, 101) 
 
1.5 mRNA structures control mRNA degradation 
The degradation of mature mRNAs is elaborately regulated. Most eukaryotic mRNAs are 
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destructed through the deadenylation-dependent pathway at the end of their lives. This pathway 
is initiated by the shortening of the 3′ poly(A) tail by deadenylases such as Pan2-Pan3, Ccr4-Not, 
PARN, etc. Subsequently, the exosome carries out the 3′ to 5′ decay of the transcript, which is 
then followed by decapping and the 5′ to 3′ decay. In addition, mRNAs can also be degraded via 
the deadenylation-independent decapping and the endonucleolytic decay pathways (reviewed in 
(113)).  
Most of the RNases responsible for mRNA degradation, such as the exosome, XRN1, and 
IRE1, prefer single-stranded substrates (114–116). Therefore, mRNA structures containing 
double-stranded elements can passively protect the mRNAs against digestion. The stem-loop 
structure at the 3′-end of a canonical histone mRNA strongly inhibits the activities of 3′ to 5′ 
exonucleases, and the efficient decay requires the helicase Upf1 to resolve the double-stranded 
stem (117, 118, Chapter II). Another example of a stabilizing mRNA structure can be found in 
the 3′-UTR of rat brain-derived neurotrophic factor (BDNF) mRNA, where an 130-nt long stem-
loop prolong the half-life of the transcript by 3-fold (119).  
Apart from the passive protective effects, mRNA structures can actively recruit the 
degradation machinery to promote mRNA decay. The constitutive decay element (CDE) stem-
loop found in the 3′-UTR of multiple pro-inflammatory mammalian genes such as TNF-α, ICOS, 
CSF-3, etc. is recognized by the RNA-binding protein Roquin, which in turn recruits the Ccr4-
Not deadenylase complex (120, 121, Chapter III). Interestingly, the mRNA encoding Roquin 
also contains a CDE stem-loop, suggesting a negative feedback regulatory mechanism. Similarly, 
the yeast RPS28B protein binds to a stem-loop in the 3′-UTR of its own mRNA, thus recruiting 
the decapping enhancer Edc3 and promoting the degradation of the mRNA through the 
deadenylation-independent decapping pathway (122).  
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Some eukaryotic mRNA structures control mRNA stability by responding to the cellular 
levels of ions and small molecules, sharing similarities with the riboswitches. The mRNAs 
encoding proteins involved in iron acquisition and utilization contain stem-loop structures named 
the iron-responsive elements (IREs) in their 5′ or 3′-UTRs (104). While the 5′-UTR IREs mostly 
repress translation initiation (Table 3), the 3′-UTR IREs can stabilize corresponding mRNAs. 
Unlike riboswitches, IREs do not bind iron directly. They instead associate with the IRE/iron 
regulatory proteins (IRPs), which are bifunctional proteins with mutually exclusive iron-
dependent aconitase and IRE-binding activities (123–127). Apo IRPs are capable of recognizing 
and stabilizing the IREs, while IRPs with their [Fe-S] clusters loaded undergo conformational 
changes that prevent RNA-binding (128). The IRE/IRP system hence senses the cellular 
concentration of iron and controls the translation and stability of target mRNAs.  
 
1.6 Conclusion 
The notion that mRNA simply acts as the intermediate between the keeper of genetic 
information (DNA) and the effector of biological functions (protein) is long obsolete. It has been 
widely appreciated that the intricate secondary and tertiary structures of mRNAs enable them to 
control many aspects of gene expression either individually or in collaboration with other RNAs 
or proteins. This chapter briefly summarizes the current knowledge on the pivotal roles played 
by eukaryotic mRNA structures in the processing, localization, translation and degradation of 
mRNAs. Recent progress in genome-wide in vivo mRNA structure probing will definitely 
accelerate the identification of novel regulatory mRNA structures as well as their protein 
partners in the near future. Nonetheless, how these mRNA structures are specifically recognized 
by the corresponding RNA-binding proteins remains largely unknown on account of the scarcity 
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of the high-resolution atomic structures of such protein-RNA complexes.  
In this dissertation, I present the major findings from my research on the crystal 
structures and functions of protein-RNA complexes containing mRNA stem-loop structures. 
Chapter II focuses on a ternary complex including the highly conserved histone mRNA stem-
loop, the stem-loop binding protein (SLBP) and the 3′ to 5′ exonuclease 3′hExo. My structural 
studies have revealed the extensive protein-RNA interfaces in this complex as well as the 
specific RNA-recognition modes of the two proteins, which result in the exceptional stability of 
the complex and contribute to the extremely efficient processing, translation and degradation of 
histone mRNAs during the S-phase of cell cycle. My research chronicled in Chapter III, on the 
other hand, concentrates on a less conserved mRNA stem-loop named the constitutive decay 
element (CDE), which is responsible for repressing the expression of multiple pro-inflammatory 
cytokines. Structural and functional studies on two CDE RNAs in complex with the versatile 
RNA-binding protein Roquin surprisingly unraveled Roquin’s ability to bind both stem-loop and 
double-stranded RNAs. The results of my dissertation have solved a problem that perplexed the 
community for almost two decades (Chapter II), and have shed light on the ongoing investigation 
into a mechanism important for autoimmune diseases (Chapter III). 
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Structural studies of the histone mRNA stem-loop, stem-loop 
binding protein and 3′hExo ternary complex* 
 
2.1 The SL-SLBP-3′hExo ternary complex is the master regulator of the 
metabolism of canonical histone mRNAs 
2.1.1 The metabolism of canonical histone mRNAs is unique among metazoan mRNAs 
There are two classes of histone proteins in metazoans. Canonical histones (also called 
DNA replication-dependent histones) H1, H2A, H2B, H3 and H4 are responsible for de novo 
chromatin packaging, while variant histones, notably H3.3, H2A.Z, CENP-A, macroH2A and 
H1.0, are important for chromatin remodeling, centromere function and epigenetic silencing (1–
3). The synthesis of canonical histones is coordinated with the cell cycle, and their mRNAs are 
both intronless and unpolyadenylated, being unique among metazoan mRNAs (4). In contrast, 
variant histones are constitutively expressed, and their transcripts carry poly(A) tails (5, 6). This 
chapter will primarily focus on the pivotal roles the SL-SLBP-3′hExo ternary complex plays in 
the metabolism of canonical histone mRNAs. 
The demand for canonical histones during the S-phase of cell cycle is enormous, with an 
estimated 500 million molecules of these proteins being translated and deposited onto the 
chromatin within a period of several hours (7). The surge in histone synthesis is reflected by the 
elevated level (35-fold increase) of canonical histone mRNAs at the beginning of the S-phase, 
which results from the combination of transcription activation (3.5-fold increase) and enhanced 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
* For convenience, the histone mRNA stem-loop, stem-loop binding protein and 3′hExo ternary complex will be 
referred to as the SL-SLBP-3′hExo ternary complex throughout this chapter. 
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pre-mRNA processing (10-fold increase). Such high level of mRNA is maintained throughout 
the S-phase unless DNA synthesis is inhibited, which can reduce the abundance of canonical 
histone mRNAs by as much as 95% (8). Once the S-phase concludes, the level of canonical 
histone mRNAs returns to normal, as a consequence of ceased transcription, downregulated pre-
mRNA processing, as well as reduced mRNA half-lives (Figure 1) (9).  
 
Figure 1. Schematic drawing of the level of canonical histone mRNAs during the cell cycle. 
This figure is adapted from (3). The horizontal axis shows the different phases of the cell cycle 
and does not necessarily represent the actual lengths of these stages. The vertical axis is in log 
scale. 
2.1.2   The SL-SLBP-3′hExo ternary complex controls the 3′-end processing, translation 
and degradation of canonical histone mRNAs 
Canonical histone pre-mRNAs carry no introns, so their processing skips the splicing 
step. Their 5′-capping is similar to that of other mRNAs, while the 3′-end processing entails only 
one step of endonucleolytic cleavage as opposed to the coupled cleavage/polyadenylation 
reactions of polyadenylated mRNAs (Figure 2). The 3′-UTR of canonical histone pre-mRNA 
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does not have the AAUAAA polyadenylation signal and instead contains two signature cis- 
elements. One is a highly-conserved stem-loop (SL) structure that is 25-50 nucleotides 
downstream of the open reading frame, the other is a purine-rich segment further downstream 
named histone downstream element (HDE) (10, 11). The SL forms a ternary complex with the 
stem-loop binding protein (SLBP) and the 3′ to 5′ exonuclease 3′hExo (12). HDE, on the other 
hand, is able to recruit U7 snRNP through base-pairing with the 5′-extension of U7 snRNA (13). 
A zinc-finger protein named ZFP100 interacts with both SLBP and U7 snRNP, and is crucial for 
efficient 3′-end processing, presumably through stabilizing the processing complex (14). The 
Zn2+-dependent endonuclease CPSF-73, in complex with other CPSF and CstF subunits, 
associates with the processing complex and performs the cleavage reaction three to five 
nucleotides downstream of the stem (15, 16). The 3′-end processing machinery of canonical 
histone mRNAs is summarized in Figure 3A.  
 
Figure 2. The processing pathways of polyadenylated mRNAs and canonical histone mRNAs. 
The thin lines represent the untranslated regions while the filled rectangles represent the coding 
regions. The stem-loop structure in the 3′-UTR of canonical histone mRNAs is shown. 
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Figure 3. (A) Schematic drawing of the sequence elements and the protein factors involved in 
the 3′-end processing of canonical histone mRNAs. The endonuclease CPSF73 is highlighted, 
with the scissor representing the cleavage site. CPSF, cleavage and polyadenylation specificity 
factor. CstF, cleavage stimulation factor. FLASH, the FLICE-associated-huge-protein, interacts 
with Lsm11 and recruits CPSF73 to the processing complex. (B) The consensus sequence of the 
histone mRNA stem-loop. The numbering scheme of the nucleotides in the SL is also shown. 
The 5′-capped and 3′-cleaved histone mRNA, accompanied by SLBP and 3′hExo, is then 
exported into the cytoplasm by the antigen peptide transporter (17). SLBP is required for the 
export process as knockdown of SLBP results in nuclear retention of histone mRNA and arrest 
of cell growth (18). 
Once exported into the cytoplasm, canonical histone mRNAs are efficiently translated on 
polyribosomes (19). All known eukaryotic mRNAs are circularized during the initiation stage of 
translation. The circularization of polyadenylated mRNAs is mediated by the eukaryotic 
translation initiation factor 4-γ (eIF4G) that recruits the 40S ribosomal subunit, the 5′-cap 
binding protein eIF4E, and the poly(A) binding protein (PABP) (20). Since mature canonical 
histone mRNAs lack the poly(A) tails, SLBP instead is responsible for the communication 
between the 5′ and 3′-ends of histone mRNAs (21). The interaction between SLBP and eIF4G is 
mediated by the SLBP interaction protein 1 (SLIP1), which binds to a segment in the N-terminal 
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domain (NTD) of SLBP (22). SLBP and SLIP1 hence help circularize histone mRNA and 
achieve the efficient translation of histone mRNAs through a mechanism similar to that of 
polyadenylated mRNAs. 
The rapid translation of canonical histones is restricted to the S-phase, so it is necessary 
to eliminate most of the existing canonical histone mRNAs when the cell progresses into the G2-
phase. Canonical histone mRNAs are degraded simultaneously from both ends. The 5′-end 
degradation is similar to that of polyadenylated mRNAs, with the decapping enzymes removing 
the 5′-cap and the exonuclease XRN1 processively digesting the mRNA in a 5′ to 3′ manner (23). 
Digestion of the mRNA from the 3′-end, however, is less straightforward. The double-stranded 
stem-loop bound by SLBP strongly inhibits the activity of 3′ to 5′ exonucleases. Therefore the 
destruction of SLBP is required for the degradation to initiate. At the end of the S-phase, the 
phosphorylation of a number of residues in the NTD of SLBP triggers the polyubiquitination of 
this protein and the subsequent protein degradation through the ubiquitin-proteasome system 
(24–26). The exposed 3′-end then undergoes oligouridylation through a mechanism that is still 
poorly characterized (23, 27). The mRNA carrying the oligo(U) tail is then degraded by 3′hExo 
and the exosome, with the assistance of the Lsm1-7 complex and the helicase Upf1 (28).  
Thus it can be seen that, the SL-SLBP-3′hExo ternary complex is crucial for almost every 
stage of the metabolism of canonical histone mRNAs, including pre-mRNA processing, mRNA 
transport, translation and mRNA decay. Consequently, the disruption of the ternary complex 
would result in genomic instability and impaired cell proliferation (29). This important complex 
has been the subject of numerous biochemical, biophysical and structural studies over the last 
two decades, and the large body of knowledge accumulated will be summarized in the following 
section. 
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2.1.3 The components of the SL-SLBP-3′hExo ternary complex 
The histone mRNA stem-loop 
The histone mRNA stem-loop (SL) is present at the 3′-UTR of all canonical histone 
mRNAs and is evolutionarily conserved (30). In human, this 26-nt sequence element contains a 
6-bp stem, a tetraloop and the 5-nt flanking sequences on both ends (Figure 3B). Of the 6 base 
pairs in the stem, the second (G7-C20) and the sixth (U11-A16) are invariant across all organisms, 
while slight differences in the other four are tolerated during evolution. The bases of the 4 
nucleotides in the loop are predominantly pyrimidines. Positions 12 and 14 are occupied by 
uridines in all model organisms except C. elegans, where position 12 is always a cytidine (30, 
31). Histone pre-mRNA 3′-end processing in C. elegans is mediated by SLBP and miRNAs, as 
this organism lacks U7 snRNP (32). The bases in the less conserved flanking sequences are 
primarily cytidines and adenines, probably in order to prevent deleterious base pairing between 
the two overhangs (Figure 4).  
Mutational studies on the SL showed that certain nucleotides are more important for the 
formation of the SL-SLBP-3′hExo ternary complex. The transversion of the G7-C20 base pair in 
the stem dramatically weakens the SL-SLBP interaction, whereas the transversion of any of the 
other five base pairs hardly affects the binding of either protein. In the tetraloop, mutating the 
uracil at position 12 or 14 into an adenine moderately impairs the protein-RNA interactions, 
while two or more simultaneous transversions in the loop will completely dismantle the complex. 
In addition, truncation of three or four bases from the 5′ flanking sequence lowers the SL’s 
affinity for SLBP. On the other hand, the binding of 3′hExo requires the proper length of the 3′ 
flanking sequence as a 3′ tail too short (< 3nt) or too long (> 10nt) can appreciably destabilize 
the SL-3′hExo binary complex (33–35).  
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Two NMR structures of the SL alone in solution were obtained in 2002. In both 
structures, the stem and the tetraloop are fairly well traced, while the flanking sequences are 
rather dynamic. The stem is in the conformation of the A-form double-stranded RNA, whereas 
the tetraloop adopts rather different shapes in the two structures. Dejong et al.’s report, using an 
RNA molecule similar to the one shown in Figure 3B, showed that all the bases in the tetraloop 
except C15 form π-stacking interactions with the U11-A16 base pair (36). Zanier et al.’s study, on 
the other hand, used a 2bp GC-clamp at the bottom of the stem to stabilize the molecule, 
resulting in both U12 and C15 flipped out (37). The NMR structures indicate that the tetraloop of 
the SL is highly dynamic in solution, and its unbound conformation may be starkly different 
from that in the ternary complex.  
 
Figure 4. Alignment of the sequences of histone pre-mRNAs near the stem-loop. The 
consensus sequence is highlighted in cyan. C. elegans histone mRNAs have a C at the first 
position of the loop (in red), distinct from the others. The cleavage site indicates the end of 
mature mRNAs (32). The sequences are obtained from (30).  
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SLBP 
SLBP, also known as hairpin binding factor (HBF), is found in all metazoans and is a 31-
kD protein in human (Figure 5A). A segment (residues 89-105) in its NTD binds to SLIP1 and is 
essential for promoting the translation of canonical histone mRNAs (Figure 3A). The 
phosphorylation of residues Ser20, Ser23, Thr60 and Thr61 in its NTD is correlated with the 
polyubiquitination and degradation of this protein (24–26). Thr60 and Thr61 are phosphorylated 
by cyclin A/CDK1, while the kinase responsible for phosphorylating Ser20 and Ser23 is yet to be 
identified (25). Following the NTD, there is a highly conserved 70-residue RNA binding domain 
(RBD) that interacts with the SL with dissociation constant (Kd) of around 10 nM. 
Phosphorylation of the Thr171 residue within the RBD can further lower the Kd by 7-fold (38). 
The prolyl isomerase Pin1 may also help protein phosphatase 2A (PP2A) dephosphorylate 
Thr171 at the end of the S-phase, thereby promoting the dissociation of SLBP from the SL (26). 
Immediately C-terminal of the RBD is a 20-residue segment that is dispensable for RNA binding 
yet required for efficient 3′-end processing (39). The C-terminal domain of SLBP is poorly 
conserved, and little is known about its function.  
Electrophoresis mobility-shift assays as well as yeast three-hybrid assays identified 
multiple conserved residues in the RBD, mostly basic and aromatic ones, as essential for the 
formation of the SLBP-SL complex (40, 41). Nevertheless, it was unclear whether these residues 
directly contact the SL or the mutations simply jeopardize the structural integrity of SLBP. 
3′hExo 
3′hExo, also named Eri-1, is a member of the DEDD family of 3′ to 5′ exonucleases that 
digest single-stranded RNAs (34). The activity of 3′hExo depends on two Mg2+ ions coordinated 
by four invariant acidic residues (DEDD) at its active site (42). In addition to the nuclease 
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domain, 3′hExo also contains an N-terminal SAP domain previously characterized as a nucleic 
acid binding motif (Figure 5A) (43). In cultured human cells, 3′hExo can trim up to two 
nucleotides from the 5-nt 3′ flanking sequence of mature histone mRNAs generated by 
endonucleolytic cleavage (28). Although the biological significance of this event remains 
obscure, it is believed that SLBP protects the mRNA from being further digested by 3′hExo (35). 
3′hExo also participates in the rapid degradation of canonical histone mRNAs at the end of the S-
phase (section 2.1.2). Besides its roles in canonical histone mRNA metabolism, 3′hExo is critical 
for trimming the 3′-end of the 5.8S rRNAs as well as regulating miRNA homeostasis (44, 45).  
Cooperative binding of 3′hExo and SLBP to the SL was observed in two experiments. 
Dominski et al. discovered that SLBP can facilitate the formation of the ternary complex when 
the concentration of the SL is too low for 3′hExo alone to bind (34). Later, Yang et al. found that 
the Y151F mutant of SLBP, which interacts with the SL very weakly, can form the ternary 
complex in the presence of wild-type 3′hExo (35). The cooperativity was attributed to the direct 
contact between SLBP and 3′hExo in the ternary complex, despite that no such interaction could 
be detected either in vitro or in vivo.  
The crystal structure of the nuclease domain of 3′hExo in complex with AMP was 
published in 2004 (42). Furthermore, the crystal structure of the SAP and nuclease domains of 
3′hExo in complex with the SL was deposited to the PDB in 2006 (PDB ID: 1ZBH). In this 
structure, however, the SL interacts with the nuclease domain of one 3′hExo molecule and the 
SAP domain of a neighboring molecule in the same asymmetric unit, indicating that the structure 




Figure 5. (A) Domain organization (upper half of each bar) and sequence conservation (lower 
half of each bar) of human SLBP and 3′hExo. The degree of conservation is indicated in color 
scale. The segment following the RBD of SLBP dispensable for binding to the SL yet essential 
for the 3′-end processing of canonical histone mRNAs is colored in magenta. (Produced with 
the program Bargraf, Tong L., unpublished) (B) Sequence alignment of the RBD of SLBP. The 
secondary structure elements based on the structure of the SL-SLBP-3′hExo ternary complex 
are shown. Dashed lines indicate residues that are disordered in the crystal, and dots indicate 
gaps in the alignment. Residues in contact with the SL are marked with the red asterisks. (C) 
Sequence alignment of 3′hExo. Secondary structure elements in the SAP domain (yellow) and 
the nuclease domain (green) are shown. The four acidic residues that coordinate the metal ions 
are indicated with the red triangles. Residues in contact with the SL are marked with the red 
asterisks. Residues N-terminal of the SAP domain are not shown. 
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2.2 Crystal structure of the SL-SLBP-3′hExo ternary complex 
2.2.1 Experimental procedures 
Protein expression and purification 
Residues 55-349 of human 3′hExo were sub-cloned into the pET-24d vector (Novagen) 
and the recombinant protein carried a C-terminal 6×His-tag. Residues 125-223 of human SLBP 
were sub-cloned into the pET-28a vector (Novagen), which introduced an N-terminal 6×His-tag. 
BL21 (DE3) Star cells transformed with either plasmid were induced with 0.4 mM IPTG and 
allowed to grow at either 16 °C (for 3′hExo) or 24 °C (for SLBP) for 18 h. The soluble proteins 
were purified through nickel-agarose affinity (Qiagen) and cation-exchange (SP Sepharose Fast 
Flow; GE Healthcare) chromatography. Particularly for the purification of SLBP, 0.2% Triton X-
100 was included in the elution buffer for nickel-agarose affinity chromatography to enhance 
SLBP’s solubility. The purified proteins were concentrated and stored at –80 ºC in a buffer 
containing 20 mM HEPES (pH 7.0), 500 mM NaCl, 5 mM DTT and 5% (v/v) glycerol. The His-
tags were not removed prior to crystallization. 
The selenomethionyl human 3′hExo (55-349) protein was produced in E. coli B834 
(DE3) cells and the bacteria were grown in defined LeMaster medium supplemented with 
selenomethione (46). The purification protocol is the same as that for the native protein.  
The 26-nt stem-loop RNA was purchased from Integrated DNA Technologies (IDT). It 
was annealed by heating to 95 °C for 2 minutes followed by cooling in ice water for 5 minutes. 
To form the SL-SLBP-3′hExo ternary complex, the proteins and the RNA were mixed with 1:1:1 
stoichiometry and incubated on ice for 30 minutes prior to purification by gel-filtration 
chromatography (Sephacryl S-300; GE Healthcare). Fractions corresponding to the ternary 
complex were collected and concentrated to 5 mg/mL in a buffer containing 20 mM HEPES (pH 
! 39 
7.0), 300 mM NaCl, 5mM DTT and 5% (v/v) glycerol.  
Protein crystallization  
Initial crystals of the ternary complex were obtained with the hanging-drop vapor-
diffusion method at 20 °C. The reservoir contains 8% (w/v) Tacsimate (pH 6.0) (Hampton 
Research) and 18% (w/v) PEG3350 (Sigma-Aldrich). The quality of the crystals was 
significantly improved through macroseeding and the inclusion of 10 mM hexaaminecobalt (III) 
chloride (Hampton Research) as an additive in the crystallization drop. Two related crystal forms 
were observed, both belonging to space group P212121, with unit cell parameters of a = 81.8 Å, b 
= 90.8 Å, c = 128.6 Å or a = 75.6 Å, b = 90.6 Å, c = 128.1 Å. There is one SL-SLBP-3′hExo 
ternary complex and one SL-3′hExo binary complex in the asymmetric unit. The structure in the 
first crystal form is described here, and that in the second crystal form is generally similar.  
Data collection and structure determination 
A single-wavelength anomalous diffraction (SAD) data set to 2.6 Å resolution (in the first 
crystal form) was collected on an ADSC charge-coupled device at the X29A beamline of 
National Synchrotron Light Source (NSLS). The diffraction images were processed and scaled 
with the HKL package (47).  
The nuclease domain of 3′hExo was located in the crystal with the program COMO (48), 
using the previously reported structure of this domain as the search model (42). The Se sites (18 
total for the two 3′hExo molecules) were located in an anomalous difference electron density 
map using preliminary phases calculated based on the nuclease domain. Reflection phases were 
calculated and improved based on the SAD data with Solve/Resolve (49), which also 
automatically built a majority of the residues. The atomic model was completed with manual 
building with the program Coot (50). The structure refinement was carried out with the program 
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CNS (51). The data collection and structure refinement statistics are summarized in Table 1. 
Table 1. Data collection and refinement statistics of the SL-SLBP-3′hExo ternary 
complex 
 
Resolution range (Å) 1 40-2.6 (2.69–2.6) 
Redundancy 4.5 (4.0) 
Rmerge (%) 8.5 (43.9) 
I/σI 15.1 (3.1) 
Number of reflections2 53,219 
Completeness (%) 94 (77) 
R factor (%) 18.8 (30.0) 
Free R factor (%) 25.1 (35.9) 
rms deviation in bond lengths (Å) 0.009 
rms deviation in bond angles (°) 1.4 
        1. The numbers in parentheses are for the highest resolution shell. 
        2. The Friedel pairs were kept as separate reflections during the refinement.  
Mutagenesis and electrophoretic mobility shift assays 
The SLBP and 3′hExo mutants were designed based on the structural information, 
generated with the QuikChange kit (Stratagene), and verified through sequencing. The mutant 
proteins were purified with the same protocol as the wild-type proteins.  
The SL with a 6-FAM fluorescence label at the 5′-end was purchased from IDT. Prior to 
the assays, the RNA was heated at 95 °C for 5 min and then slow-cooled to room temperature. 
20 pmol of the RNA was mixed with 20 pmol of 3′hExo and/or 30 pmol of SLBP RBD in a 
buffer containing 20 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM EDTA, in a total volume of 20 
µl and incubated on ice for 30 minutes. The samples were loaded to a 1.5% native agarose gel for 
the binary complexes and 0.5% agarose gel for the ternary complex. The electrophoresis was 
performed in 1× TAE buffer (pH 8.0) at 4 °C, and then the RNA bands were visualized on a UV 
illuminator. 
2.2.2 The overall structure of the SL-SLBP-3′hExo ternary complex 
The crystal structure of the SL-SLBP-3′hExo ternary complex was determined at 2.6 Å 
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resolution using the single-wavelength anomalous dispersion (SAD) and molecular replacement 
(MR) methods (Figure 6A) (52). The SL lies between the two proteins, with the RBD of SLBP 
binding to the 5′ side and the SAP and nuclease domains of 3′hExo binding to the 3′ side.  
All 26 nucleotides of the SL have excellent electron density (Figures 6B, 6C) and the 
double-stranded stem adopts the conformation of a slightly stretched A-form RNA with widened 
major groove (Figure 6D, Table 2). The conformation of the tetraloop is different from those of 
the solution structures, with U12, U13 and C15 flipped out and U14 stacked against the U11-A16 
base pair (Figure 6C) (36, 37). The 3′ flanking sequence follows the helical pattern of the stem 
and extends into the active site of 3′hExo. The base of A26 at the 3′-end is flipped by ~180o 
relative to C25. The ribose rings of all the four nucleotides in the loop as well as C25 adopt the 
C2′-endo conformation as opposed to the C3′-endo conformation characteristic of A-form RNAs. 
The backbone of the SL also undergoes sharp turns at these nucleotides. 
The RBD of SLBP is comprised of three α-helices (αA, αB and αC) and a long loop 
connecting αB and αC, part of which (residues 159-164) is disordered in the crystal structure. 
Most of the residues contacting the SL are located in αA and αC, while αB and the αB-αC loop 
are away from the protein-RNA interface, in agreement with an earlier report showing that 
mutations in this region have little effect on SL-SLBP interaction (41).  
3′hExo binds to the SL in a bipartite manner. The SAP domain interacts with the 
tetraloop and the apical part of the stem, while the nuclease domain recognizes the bottom part of 
the stem as well as the 3′ flanking sequence. The linker (residues 117-123) between the SAP and 
nuclease domains is disordered. Besides, the segment (residues 270-273) linking α8 and α9 in 
the nuclease domain also has poor electron density.  
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Figure 6. (A) Crystal structure of the SL-SLBP-3′hExo ternary complex at 2.6 Å (12). Two 
views related by a 90o rotation around the horizontal axis are shown. The SL is in orange, the 
RBD of SLBP is in cyan, the SAP domain of 3′hExo is in yellow and the nuclease domain is in 
green. Numbering of the secondary structure elements is also shown. The dotted lines indicate 
loops that are disordered. (B) Composite omit Fo-Fc electron density map of the SL, contoured 
at 3σ. (C) Close-up view of the tetraloop. The electron density map is the same as in (B). Red 
dashed lines indicate hydrogen bonds mediating the U11-A16 base pair. (D) Overlay of the stem 
of the SL with A-form RNA. The stem of the SL is in orange while the standard A-form RNA 
molecule is in black. Only the backbone atoms were used in the structural alignment, which was 
performed using the program Coot (50). The structure of A-form RNA was generated by the 
program 3DNA (53).  The structure figures were produced with PyMOL (54). 
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Table 2.  Helical parameters for the stem of the SL 
 
Base pair step X-disp (Å) Incline (°) Rise (Å) Twist (°) 
1-2 -3.2 9.6 3.2 38.7 
2-3 -5.0 1.2 3.0 27.6 
3-4 -7.2 11.9 2.8 25.8 
4-5 -5.3 1.1 3.1 27.2 
5-6 -5.1 2.5 3.1 27.4 
Average -5.4 5.3 3.0 29.4 
Classical A-form RNA -4.0 15.3 2.8 33.0 
 
2.2.3 Both SLBP and 3′hExo primarily recognize the shape of the SL 
The RBD of SLBP contacts the 5′ flanking sequence, the 5′ arm of the stem and the 
tetraloop of the SL via helices αA and αC, which are roughly parallel to the axis of the stem 
(Figure 7A). The deep major groove typical of A-form RNAs makes it difficult for SLBP to 
directly access the bases in the center of the stem. Therefore, SLBP recognizes the SL in a way 
that the N-termini of αA and αC interact with the 5′ end of the stem as well as the 5′ flanking 
sequence, while their C-termini are anchored to the loop (Figure 7A). This binary RNA 
recognition mode thus restricts the stem of the SL to be exactly 6-bp long to match the lengths of 
the two α-helices. 
The last three nucleotides of the 5′ flanking sequence (A3-A5) directly interact with 
residues Tyr178, Ser179, Ser182, Gln185 and Gln186 at the N-terminus of αC (Figure 7B). The 
structure is consistent with earlier studies showing that the deletion of three or four nucleotides 
from the 5′ flanking sequence substantially weakens the SLBP-SL complex while the removal of 
two nucleotides has little effect (33). At the bottom of the stem, the guanine base of G7 
(numbering scheme in Figure 3B) forms bidentate hydrogen bonds with the guanididium group 
in the side chain of Arg181 (Figure 7C). This turns out to be the only sequence-specific 
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interaction in the entire ternary complex and explains the absolute invariability of the G7-C20 
base pair in the sequences of all known histone mRNAs (Figure 4). Other nucleic acid binding 
proteins, such as the transcription factor GA-binding protein (GABP), also employ the same 
hydrogen-bonding pattern to specifically recognize guanine bases (55). SLBP interacts with the 
rest of the stem mostly through hydrogen bonds and ionic interactions between the phosphate 
backbone of the RNA and the side chains of some basic residues (Arg137, Lys140, Arg180 and 
Lys188) located in the N-terminal parts of αA and αC (Figure 7D). The distance between SLBP 
and this part of the SL is longer due to the deep major groove, and several water molecules are 
needed to mediate the protein-RNA interactions (Figure 7D). The invariant U11-A16 base pair 
have no close interactions with either protein, it instead may be crucial for the thermodynamic 
stability of the stem-loop structure (56).  
The tetraloop has intricate interactions with αA and αC in SLBP RBD as well as α1 and 
α3 in the SAP domain of 3′hExo (Figure 7E). U12 and C15 have parallel π-stacking interactions 
with the side chains of Tyr144 and His195 of SLBP respectively, while edge-to-face π-stacking 
interactions exist between Tyr66 of 3′hExo and U13 as well as Tyr144 of SLBP and U14. U12 is 
conserved across all organisms except C. elegans where it is a cytosine, and an arginine occupies 
the position of Tyr144 in C. elegans SLBP. The bases of U13, U14 and C15 also form hydrogen 
bonds with several protein residues (Lys191 of SLBP, Arg78 and Lys111 of 3′hExo). Although 
these hydrogen bonds cannot distinguish uracil from cytosine, they can only be formed with 
pyrimidine bases, consistent with the fact that most histone mRNA stem-loops include only 
pyrimidine bases in the tetraloop (Figure 4). Moreover, the bulkier purine bases may also change 
the overall shape of the loop, making it unfit for the RNA-binding surfaces of SLBP and 3′hExo. 
Apart from the direct base-protein interactions, hydrogen bonds involving the ribose rings and 
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phosphate groups of the nucleotides are also present.  
The phosphate groups in the backbone of the 3′ arm of the stem contact α1, α3 in the 
SAP domain and α8 in the nuclease domain of 3′hExo (Figure 7F). The last nucleotide in the 3′ 
arm (C21) and the first two nucleotides (A22, C23) in the 3′ flanking sequence do not closely 
interact with 3′hExo and have higher temperature factors, indicating that they are more flexible 
in solution. The last three nucleotides (C24, C25 and A26) of the SL reach deeply into the active 
site of 3′hExo (Figure 7G). The ribose ring of C24 is recognized by Arg261, while the base of C25 
stacks against the side chain of Trp233. The adenine base of A26 at the 3′-end is flipped 180o 
from C25 and inserts into a mostly hydrophobic pocket surrounded by Asn143, Phe185 and 
Leu189 (Figure 7H). A26 thus occupies the same position as the AMP molecule in the previously 
published crystal structure of the nuclease domain of 3′hExo (42), based on which we modeled 
the two Mg2+ ions (Figure 7G, pink spheres) coordinated by residues Asp134, Glu136, Asp234 
and Asp298 (the DEDD motif) given that Mg2+ ions were excluded in our crystallographic 
studies. The phosphate group of A26 is at a position ready to be attacked by a water molecule 
activated by the Mg2+ ions, consistent with the catalytic mechanism of Mg2+-dependent 
exonucleases. Beyond the A26 binding pocket, there is a channel opposite to the SL binding face 
of 3′hExo (Figure 7H, black arrow), which may possibly accommodate stem-loop RNAs with 
longer 3′ tails. However, the interaction may be weak due to the limited width as well as the 
unfavorable electrostatic potential of the channel. Furthermore, SLBP in the ternary complex 
may restrict the movement of the SL relative to 3′hExo. Therefore, the 3′ flanking sequence of 
the SL needs to be at least 3-nt long for it to extend to the active site of 3′hExo, in agreement 
with the fact that 3′hExo is capable of trimming only two nucleotides from the 3′-end of the SL 
after the endonucleolytic cleavage (28).  
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Figure 7. (A) SLBP is on the same side as the major groove of the SL. The side chain of 
Arg181 or SLBP is shown. (B) Interactions between the 5′ flanking sequence of the SL and the 
N-terminus of αC of SLBP. Red dashed lines indicate hydrogen bonds. Water molecules are 
represented as red spheres. (C) Arg181 of SLBP specifically recognizes the G7 base of the SL 
through bidentate hydrogen bonds. Simulated annealing Fo-Fc omit electron density contoured at 
5σ is shown. (D) Interactions between the 5′ arm of the stem and SLBP. (E) Protein-RNA 
interactions at the tetraloop of the SL. (F) Interactions between the 3′ arm of the stem and 
3′hExo. (G) Interactions between the 3′ end of the SL and the active site of 3′hExo. The AMP 
molecule (gray) and the two Mg2+ ions (pink spheres) were modeled in using PDB entry 1W0H. 
(H) Electrostatic surface of the active site of 3′hExo. Blue and red regions show positive and 
negative electrostatic potential, respectively. The black arrow points at a channel on the other 
side of the active site that may accommodate longer RNA substrates. 
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The complicated network of protein-RNA interactions within the ternary complex is 
summarized in Figure 8. Most of the protein residues involved in RNA recognition are conserved 
(Figures 5B, 5C). The protein-RNA interface in the SL-SLBP-3′hExo ternary complex is rather 
extensive (2150 Å2 buried area), contributing to its exceptional stability. Both SLBP and 3′hExo 
primarily recognize the shape of the SL instead of its sequence, with G7 being the only 
nucleotide specifically recognized by SLBP. The sequence of the SL probably plays a role in 
determining its shape, especially at the tetraloop where pyrimidine bases are preferred by both 
proteins. Besides, the proper lengths of the stem as well as the 5′ and 3′ flanking sequences are 
also crucial for the formation of a stable ternary complex.  
 
Figure 8. Schematic drawing summarizing the protein-RNA interactions in the SL-SLBP-
3′hExo ternary complex. The interactions involve the side chains of the protein residues unless 
the main chain atoms are otherwise labeled. Water molecules mediating the interactions are also 
shown. 
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2.2.4 Cooperative binding between SLBP and 3′hExo results from the induced-fit 
mechanism 
Dominski et al. previously hypothesized that the cooperativity between SLBP and 3′hExo 
results from direct contacts between the two proteins in the ternary complex (34). In the crystal 
structure of the ternary complex, SLBP and 3′hExo approach each other most closely near the 
C15 base of the SL with a distance of ~5 Å, suggesting that there is no direct interaction between 
them (Figure 9A).  
Clues to the mechanism underlying the cooperative binding come from the unexpected 
discovery that the asymmetric unit of the crystal contains one SL-SLBP-3′hExo ternary complex 
and one SL-3′hExo binary complex (Figure 9B). One possible reason for the heterogeneity of the 
crystal is that SLBP has poor solubility and precipitated while we prepared the solution for 
crystallization, leading to its underrepresentation in the mixture. The 5′ part of the SL in the 
binary complex with 3′hExo has poorer electron density and nucleotides C1-U9 are disordered 
(Figures 9B, 9C), providing support to the notion that SLBP binding is important for stabilizing 
the conformation of the SL. The rest of the SL in the binary complex has similar shape to that in 
the ternary complex, especially at the tetraloop (Figure 9C). With the exception of the U12 base, 
which primarily contacts SLBP in the ternary complex and is 30o away in the binary complex, 
the other three bases in the loop all occupy similar positions in both complexes. There are 
significant differences in the conformation of the loop between the crystal structures of the 
binary and ternary complexes and the SL-alone solution structures, suggesting that the formation 
of the ternary complex requires substantial rearrangement of the bases in the loop (Figures 9D, 
9E). On the other hand, the similar shapes of the loop in the binary and ternary complexes 
indicate that the binding of 3′hExo alone is capable of inducing most of the conformational 
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changes necessary for the subsequent SLBP binding. Therefore, the “induced-fit” mechanism, 
stating that the binding of one protein induces a conformation of the SL that promotes the 
binding of the other protein, explains the cooperative binding between SLBP and 3′hExo. 
 
Figure 9.   (A) Surface representation of the structures of SLBP RBD and 3′hExo in the ternary 
complex. The red arrow points at the gap between the two proteins. (B) Structure of the entire 
asymmetric unit. The ternary complex is in color and the SL-3′hExo ternary complex is in gray. 
(C) Overlay of the structures of the ternary (color) and binary (gray and black) complexes. The 
red arrow shows the direction of the slight movement of the SAP domain in the binary complex 
compared to that in the ternary complex. (D, E) Overlay of the crystal structure of the SL in the 
ternary complex (orange) and two NMR structures (gray). The rearrangement of the bases in the 
tetraloop is illustrated by the red arrows. 
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2.2.5 Verification of the crystal structure through EMSA 
To verify that the crystal structure of the SL-SLBP-3′hExo ternary complex faithfully 
reflects its native state in solution, we mutated several conserved residues in SLBP and 3′hExo 
that directly interact with the RNA based on the structure and performed electrophoretic-
mobility-shift-assays (EMSAs) to assess their ability to form stable complexes with the SL. All 
of the mutant proteins have similar cation-exchange and gel-filtration chromatography profiles as 
the wild-type proteins, indicating that their structural integrity is not disrupted by the mutations. 
For SLBP, we mutated residues that interact with the 5′ arm of the stem (R137A, R180A 
and R181A) and those that contact the loop (Y144A and H195A), with K156A as a control. 
Mutations of the residues that contact the stem substantially weakened SLBP-SL interaction, 
while the effects of the Y144A and H195A mutations are less significant (Figure 10A).  
For 3′hExo, we introduced mutations into either the SAP domain (Y66A, A70E, R78A, 
K104A and K107A) or the nuclease domain (W233A, R261A), with the K300A mutation being 
a control. Many of the mutations can destabilize the SL-3′hExo binary complex, with the Y66A, 
A70E and K107A mutations having the most obvious effects (Figure 10B), indicating that the 
SAP domain is more important than the nuclease domain for the recognition of the SL. Finally, 
we tested the effects the SLBP mutants impose on the stability of the ternary complex. The result 
is consistent with that of the SL-SLBP binary complex EMSA (Figures 10A, 10C).  
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Figure 10. (A) EMSA result of the SL-SLBP binary complexes. Smears on the gel indicate 
unstable SL-SLBP complexes that disassociated during electrophoresis. The K156A mutation is 
a control. (B) EMSA result of the SL-3′hExo binary complexes. The K300A mutation is a 
control. (C) EMSA result of the SL-SLBP-3′hExo ternary complexes with WT 3′hExo and WT 
or mutant SLBP. 
 
2.3 Crystal structure of the SL-SLBP (pT171)-3′hExo ternary complex 
2.3.1 Experimental procedures 
Protein expression and purification 
Human 3′hExo was purified in the same way as in section 2.2.1. Human SLBP with 
Thr171 phosphorylated was obtained from the Marzluff Group in UNC Chapel Hill and was 
further purified through gel-filtration chromatography (Sephacryl S-300; GE Healthcare). The 
ternary complex was prepared with the same protocol and concentrated to 1.5 mg/ml.  
Protein crystallization  
Crystals of the SL-SLBP (pT171)-3′hExo ternary complex were obtained with the 
! 52 
hanging-drop vapor-diffusion method at 20 °C. The reservoir is the same as that for the SL-
SLBP-3′hExo ternary complex. The complex would precipitate prior to forming small crystals, 
which were improved through macroseeding. The crystal form is very similar to that of the 
unphosphorylated complex, with the space group of P212121, and unit cell parameters of a=82.1 
Å, b=91.5 Å, c=128.7 Å. One SL-SLBP (pT171)-3′hExo ternary complex and one SL-3′hExo 
binary complex are present in the asymmetric unit.  
Data collection and structure determination 
A native data set to 2.3 Å resolution was collected on an ADSC charge-coupled device at 
the X29A beamline of National Synchrotron Light Source (NSLS). The diffraction images were 
processed and scaled with the HKL package (47). The structure refinement was carried out with 
the program Phenix (57). The data collection and structure refinement statistics are summarized 
in Table 3. 
Table 3. Data collection and refinement statistics of the SL-SLBP (pT171) -3′hExo 
ternary complex 
!
Resolution range (Å) 1 50-2.3 (2.38–2.3) 
Redundancy 3.5 (3.5) 
Rmerge (%) 9.2 (48.0) 
I/σI 9.5 (1.8) 
Number of reflections 40,611 
Completeness (%) 93 (85) 
R factor (%) 19.3 (27.1) 
Free R factor (%) 24.5 (32.9) 
rms deviation in bond lengths (Å) 0.008 
rms deviation in bond angles (°) 1.1 
        1. The numbers in parentheses are for the highest resolution shell. 
 
2.3.2 Phosphorylation of Thr171 enhances SL-SLBP interaction through stabilizing the 
structure of SLBP 
The crystal structure of the SL-SLBP-3′hExo ternary complex reveals that the Thr171 
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residue is located near the middle of the loop connecting αB and αC and lies on the opposite 
face of the SLBP structure from the RNA-binding site. Since residues 159-164 at the N-terminus 
of the αB-αC loop are disordered, the side chain of Thr171 is largely exposed to the solvent. 
Solely based on the structure of the ternary complex, it remained unclear why its 
phosphorylation can stabilize the SL-SLBP complex by 7-fold (38).  
In order to answer this question, we obtained insect-cell-expressed SLBP with Thr171 
phosphorylated from the Marzluff Group and solved the crystal structure of the SL-SLBP 
(pT171)-3′hExo ternary complex. The structure is highly similar to that of the unphosphorylated 
ternary complex (Figure 11A). 3′hExo and the SL are almost identical in the two structures, 
while the RMSD for all the Cα atoms of SLBP is 0.6 Å (58). The differences between the 
structures of SLBP and SLBP (pT171) are concentrated at the αB-αC loop, which is completely 
ordered in SLBP (pT171). The phosphate group on Thr171 forms salt bridges with the side 
chains of Lys146 (αA), Arg160 and Arg163, with the two arginine residues in the previously 
disordered segment of the αB-αC loop (Figure 11B). In addition, Tyr151 in αB and Trp190 in 
αC interact with the phosphate through hydrogen bonds, the latter mediated by a water molecule. 
Therefore, the phosphate group on Thr171 plays the pivotal role of bringing together the three α-
helices and the αB-αC loop, thus considerably stabilizing the structure of the RBD.  
The dephosphorylation of Thr171 is a prerequisite for the dissociation of SLBP from the 
SL at the end of the S-phase of the cell cycle (26). The crystal structure shows that the phosphate 
group on Thr171 faces towards the core of the RBD and should not be accessible to protein 
phosphatase 2A (PP2A). Thr171 is part of the highly conserved Thr171-Pro172-Asn173-Lys174 
motif (Figures 5B, 11B), and the Thr-Pro peptide bond is in the trans conformation in the crystal 
structure. Therefore, the dephosphorylation of Thr171 may require the prolyl isomerase Pin1 to 
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convert the Thr-Pro peptide bond to the cis conformation before the phosphate is recognized by 
PP2A (26). It is possible that the N-terminal part of the αB-αC loop (residues 159-172) 
undergoes significant conformational changes after the prolyl-isomerization and 
dephosphorylation events, thus exposing the hydrophobic core of the RBD and contributing to its 
eventual disintegration and dissociation from the SL. 
2.3.3 A surface on SLBP that may mediate interactions with other proteins 
The conserved Tyr151-Asp152-Arg153-Tyr154 motif in αB is near the Thr171 
phosphorylation site (Figure 11B). The two tyrosine residues participate in the network of 
intramolecular interactions that maintain the stability of the RBD, consistent with the previous 
report showing that mutating them into Phe residues lowers the affinity to the SL (41). The Asp 
and Arg residues are dispensable for the SL-SLBP interaction, proved by both the structure and 
previous biochemical studies (41). Instead, human SLBP with the Asp152-Arg153 dipeptide 
mutated fails to interact with the zinc-finger protein 100kD (ZFP100) and cannot promote the 
efficient 3′-end processing of canonical histone mRNAs, similar to the SLBP mutant with the 20-
residue segment following the RBD deleted (14, 59). Our structure shows that the Asp152-
Arg153 dipeptide is in the proximity of the C-terminus of the RBD (residue 199 in Figure 11B). 
It is probable that the segment C-terminal of the RBD as well as the Asp152-Arg153 dipeptide 
form a surface on SLBP that mediates the interactions with other protein factors such as ZFP100 




Figure 11. (A) Overlay of the crystal structures of the SL-SLBP (pT171)-3′hExo ternary 
complex (color) and the SL-SLBP-3′hExo ternary complex (gray). The side chain of the 
pThr171 residue is shown. The red arrow points to the segment in the αB-αC loop of the RBD 
that is disordered in the structure of the unphosphorylated ternary complex. (B) Interactions 
involving the phosphate group on pThr171. Hydrogen bonds and salt bridges are shown with 
red dashed lines. The red sphere is a water molecule that mediates the interaction between 
Trp190 and the phosphate group. Simulated-annealing omit Fo-Fc electron density for the 
phosphate is also shown, contoured at 3σ. The pink shaded area indicates a surface on SLBP 
that may mediate interactions with other protein factors essential for histone mRNA 3’-end 
processing. 
 
2.4 Summary and future directions 
We have solved the crystal structure of the human SL-SLBP-3′hExo ternary complex and 
revealed the unique RNA-recognition modes of the two proteins, which are highly consistent 
with the large body of biochemical and biophysical data reported previously (Tables 4, 5). 
Moreover, the structure also strongly suggests that the cooperative binding between SLBP and 
3′hExo results from the induced-fit mechanism instead of direct protein-protein interaction. We 
later obtained the crystal structure of the ternary complex with Thr171 of SLBP phosphorylated, 
which shows that the phosphate group substantially stabilizes the structure of the RBD of SLBP, 
leading to higher affinity to the SL. Finally, on the basis of the structural studies, we proposed a 
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surface on SLBP formed by αB and the 20-residue segment following the RBD, which may 
interact with other proteins important for canonical histone mRNA 3′-end processing. 
More computational, biochemical and structural studies can be performed to further 
enrich our knowledge on the ternary complex. The mechanism underlying the cooperativity 
between SLBP and 3′hExo can be better understood through simulating the dynamics of the SL 
during the process of the formation of the ternary complex with molecular dynamics (MD) 
simulation. The effects of Thr171 phosphorylation on the stability of SLBP RBD can also be 
evaluated either by simulation or biochemical assays such as fluorescence resonance energy 
transfer (FRET) and thermo-shift. Actually, a recent report (Zhang et al., unpublished) used MD 
simulation, NMR and FRET to prove that the compactness of Drosophila SLBP (dSLBP) RBD 
is enormously enhanced by the phosphorylation of Thr230 (equivalent to Thr171 of human 
SLBP) as well as the segment C-terminal of the RBD, thus increasing the proportion of dSLBP 
molecules in the optimal conformation for binding to the SL.  
There is no evidence showing that the flexible 20-residue segment following the RBD in 
human SLBP is phosphorylated. Accordingly, we are more interested in its potential role of 
interacting with other processing factors, such as ZFP100. It is very likely that this segment will 
no longer be flexible in the structure of the SL-SLBP-3′hExo-ZFP100 quaternary complex. 
Moreover, the C-terminal extension of Lsm4 has been lately shown to interact with both SLBP 
and 3′hExo in the ternary complex (60). It is therefore of our interest to add more proteins to the 





Table 4. Structural interpretation of observations on SLBP and 3′hExo mutants 
reported earlier 
 
Mutation(s) Observations Structural interpretation 
Yeast three-hybrid assays on mutations in the SLBP RBD (40). Observations are maximum 3-
amino-1,2,4-triazole (3-AT) concentration allowed for growth. Wild-type SLBP allows growth at 
>225 mM 3-AT.  
R137A + R138A 2.5 mM 3-AT 
R137 interacts with the SL, R138 is 
important for maintaining the structural 
integrity of the RBD. 
T171A/T171I 50/200 mM 3-AT T171 is phosphorylated, which enhances binding by 7-fold (38). 
E157K 100 mM 3-AT E157 is in helix aB, not interacting with SL and on the surface of the RBD. 
R181Q/R181C 12/15 mM 3-AT R181 recognizes the guanine base of the second base pair of the stem. 
D184N 2 mM 3-AT 
D184 interacts with the SL through two 
waters, it also ion pairs with Arg180, which 
interacts with SL. 
Electrophoretic mobility shift assays (EMSA) on mutations in the SLBP RBD (61).  
144-YGKNT-148 
(human SLBP) to 
RAKEK (C. elegans 
SLBP) 
WT RBD has Kd of 4 
nM for mouse and C. 
elegans SL. Mutant 
RBD has Kd of 5 nM for 
the C. elegans SL, but 
binds poorly to mouse 
SL.  
Mouse and human SLs have a U at the first 
position of the loop, while C. elegans SL 
has a C at this position. Y144 is π-stacked 
with this base. The Y144R mutation, 
together with the other changes, affect the 
recognition of this base.  
175-FKKY-178 
(human SLBP) to 
LINF (C. elegans 
SLBP) 
Makes human SLBP 
RBD specific for C. 
elegans SL, and it binds 
weakly to mouse SL.  
Y178 is located near the 5′ flanking 
sequence of the SL.  
Electrophoretic mobility shift assays (EMSA) on mutations in the SLBP RBD (41). 
Observations are binding affinity relative to wild-type (%). 
R137A + R138A 0 
R137 interacts with the SL, R138 is 
important for maintaining the structural 
integrity of the RBD.  
Q139A + K140A + 
Q141A 0 K140 interacts with the SL.  
K146R/K146A 100/5 
K146 forms a salt-bridge with the 
phosphate on T171 and is not involved in 
SL binding. 
Y151F + Y154F 
Y151S + Y154S 




Y151 interacts with the phosphate on T171. 
Neither residue is involved in SL binding. 
H168F 5-10 H168 is not involved in SL binding. 
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W183I + W190I 0 Both residues are in the hydrophobic core of the RBD.  
Yeast three-hybrid assays on mutations in the SLBP RBD (62). Observations are maximum 3-
AT concentration allowed for growth. Wild-type SLBP allows growth at >225 mM 3-AT. 
G145R/G145T 7.5/100 mM 3-AT 
G145 does not interact with SL. There is no 
space for the large Arg side chain in the 
structure while the smaller Thr side chain 
can be accommodated. 
P172S/P172L No growth/5 mM 3-AT P172 is important for T171 phosphorylation.  
R181H 12.5 mM 3-AT R181 recognizes the G7 base in the stem. 
D184N 2.5 mM 3-AT  
D184 interacts with the SL through two 
waters, it also forms an ion pair with 
Arg180, which interacts with the SL. 
Electrophoretic mobility shift assays (EMSA) on mutations in 3′hExo (35). Observations are 
binding affinity relative to wild-type (%). 
Deletion 76-110 0 Residues 76-110 are part of the SAP domain (excluding helix a1).  
K92A 100 K92 does not interact with SL and does not have a structural role.  
K99A 100 K99 does not interact with SL and does not have a structural role. 
K104A 100 K104 interacts with the phosphate of A18 of SL.  
K92A + K104A 100 See above 
R105A 0 R105 does not interact with SL. It is important for structural integrity.  
Y109A + Y110A 100 Neither residue interacts with SL.  
K111A + K112A 0 K111 is hydrogen-bonded to the base of U13.  
 
Table 5. Structural interpretation of observations on SL mutants reported earlier 
 
Mutation(s) Observations Structural interpretation 
Nitrocellulose filter binding assays on the affinity of Xenopus SLBP1 for the SL (33). 
Observations are changes in Kd relative to that for the wild-type SL, which is 1.5 nM. 
Transversion of all the 
base pairs in the stem >200× 
The G7-C20 base pair is specifically 
recognized by SLBP. The shape of the stem 
is recognized by SLBP, while the 
transversion of the entire stem will change 
its shape. 
Transversion of the 
G7-C20 base pair >200× See above. 










SLBP. Yet the mutation may slightly alter 
the shape of the stem.  
U11-A16 to U11-G16 14.8× 
The U-G wobble pair will disrupt the shape 
of the stem, which is important for SLBP 
binding. 
Tetraloop 
UUUC to AUAC 
UUUC to GUUA 
UUUC to GUAA 
UUUC to AUUC 







SLBP recognizes the shape of the tetraloop. 
Mutating the pyrimidine bases into bulkier 
purine bases will disrupt SLBP binding.  
5′ flanking sequence 
Δ2 nts from the 5′-end 
Δ3 nts from the 5′-end 





SLBP directly interacts with the last 3 nts in 
the 5′ flanking sequence. 
3′ flanking sequence 
Δ2 nts from the 3′-end 
Δ4 nts from the 3′-end 
Δ5 nts from the 3′-end 






SLBP does not interact with the 3′ flanking 
sequence. Yet the deletion of the entire 3′ 
tail will destabilize the conformation of the 
SL. Also, the GGGCA 3′ flank may form 
base pairs with the 5′ flank and alter the 
shape of the SL. 
Immuno-precipitation assays on the affinity of human SLBP and 3′hExo for the SL (34). 
Observations are binding affinity relative to wild-type (%). The first number is for SLBP and the 
second number is for 3′hExo.  
Transversion of  
G6-C21 
G7-C20 
G7-C20 + C8-G19 






Only the G7-C20 base pair is specifically 
recognized by SLBP. However, both 
proteins also recognize the shape of the 




UUUC to AUAC 
UUUC to AUUC 





SLBP and 3′hExo recognize the shape of 
the tetraloop. Mutating the pyrimidine bases 
into bulkier purine bases will disrupt protein 
binding. 
5′ flanking sequence 




SLBP directly interacts with the last 3 nts in 
the 5′ flanking sequence while 3′hExo does 
not. 
3′ flanking sequence 
ACCCA to AAACC 
Δ4 nts from the 3′-end 
Δ5 nts from the 3′-end 






SLBP does not interact with the 3′ flanking 
sequence. The 3′ flanking sequence needs to 
be 3-nt to 5-nt long to be properly 
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The ROQ domain of Roquin recognizes the constitutive decay 
element (CDE) as well as double-stranded RNA 
 
3.1 Roquin recognizes the CDE and regulates the expression of multiple 
genes 
3.1.1 The CDEs are present in the mRNAs of TNFα  and other cytokines 
Tumor necrosis factor alpha (TNF-α) is a highly potent pro-inflammatory cytokine (1). 
Primarily synthesized and released by macrophages, TNF-α is actively transcribed when 
bacterial lipo-polysaccharide (LPS) triggers the binding of NF-kB and other transcription factors 
to the TNF-α promoter (2). TNF-α is an important modulator of the immune response to 
infection and injury, yet inappropriate or excessive release of TNF-α could result in severe 
inflammatory disease such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel 
disease and psoriasis (3). Immune cells that produce TNF-α hence have developed several 
mechanisms to tightly control its expression. The 3′-UTR of TNF-α contains an AU-rich element 
(ARE) that interacts with a variety of ARE-binding proteins which can suppress translation and 
promote mRNA decay (4). Moreover, the microRNA miR-125b also participates in the 
destabilization of TNF-α transcripts (5). Both the ARE and microRNA pathways are temporarily 
downregulated in macrophages stimulated by LPS, whereas the degradation of TNF-α mRNA 
through the constitutive decay element (CDE) remains active (6).  The CDE pathway hence 
represses the expression of this potentially harmful cytokine under pro-inflammatory conditions 
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and limits LPS-induced pathologic processes. 
CDE is a conserved cis-element first identified downstream of the ARE in the 3′-UTR of 
TNF-α mRNA (6). It was later appreciated that CDEs also exist in the 3′-UTR of mRNAs of a 
number of other genes, most of which encode cytokines or proteins that are involved in T-cell 
differentiation, B-cell memory, autoimmunity, etc. (7) The most recognizable feature of the CDE 
is an RNA stem-loop structure containing a 3-nt loop and a stem comprised of five to eight base 
pairs. The consensus sequence of the triloop includes a purine in the center with two pyrimidine 
bases (mostly uracils) on the side, while the sequence of the stem may vary (Figure 1A).  
The capability of the CDE to destabilize the corresponding mRNAs also depends on the 
sequences flanking the stem-loop structure. Altering the flanking sequences of the CDE stem-
loop of TNF-α can increase the half-life of the mRNA by 6-fold, while the stem-loop alone in 
the absence of the flanking sequences is sufficient for efficient mRNA decay (7). Moreover, a 
second stem-loop 9 bases upstream of the CDE stem-loop of colony stimulation factor 3 (CSF-3) 
was reported to be important for destructing the transcript (8). The flanking sequences of CDE 
stem-loops share no conserved feature in either primary sequence or secondary structure. It 
therefore remains unclear whether they actively participate in the mRNA decay process, or their 
presence passively assures the correct formation of CDE stem-loops in vivo.  
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Figure 1. (A) Sequences of CDE stem-loops of a number of human genes. ICOS, inducible T-
cell co-stimulator. Ier3, immediate early response 3. Bmpr1a, bone morphogenetic protein 
receptor, type IA. Hmgxb3, HMG box domain containing 3. NFκBiz, nuclear factor of kappa 
light polypeptide gene enhancer in B cells inhibitor, zeta. Ppp1r10, protein phosphatase 1, 
regulatory subunit 10. CSF-3, colony stimulating factor 3 (granulocyte). (B) Schematic drawing 
of the mechanism of CDE-mediated mRNA decay.  
3.1.2 Roquin recognizes the CDE and promotes mRNA decay 
Roquin was first characterized by Vinuesa et al. in 2005, as the murine homozygous 
Roquin M199R mutant (named sanroque or san mutant) causes the accumulation of follicular 
helper T (Tfh) cells and spontaneous formation of germinal centers without immunization (9). 
These physiological effects lead to severe systemic lupus-like autoimmune phenotypes, which 
can be attributed to excess inducible T cell costimulator (ICOS), whose expression is normally 
repressed by Roquin at the post-transcriptional stage through the CDE-dependent mRNA decay 
pathway (10). Mice with homozygous Roquinsan mutations are also prone to develop small 
intestine inflammation, while heterozygosity for Roquinsan was reported to be responsible for the 
growth of angioimmunoblastic T-cell lymphoma-like tumors (11, 12). Apart from controlling 
immune responses, Roquin may also be crucial for embryonic development since germ-line 
knockout of Roquin results in perinatal lethality related to impaired lung development (13).  
Roquin is a large protein (1,133 residues in human) found in most metazoans. It contains 
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an RING-finger domain, the ROQ domain, and a CCCH-type zinc-finger (ZF) motif in the 
highly conserved N-terminal part (Figure 2A). The RING domain may possess E3 ubiquitin 
ligase activity, since the Roquin homolog in C. elegans, RLE-1, has been shown to catalyze the 
polyubiquitination of DAF-16 protein, hence accelerating its degradation (14). The ROQ domain 
is a novel RNA-binding domain without known sequence homolog. It alone is sufficient for 
recognizing the CDE stem-loops in an array of proinflammatory genes such as TNF−α, ICOS, 
Ier3, etc. (15) . The ZF of Roquin is not essential for the interaction with the CDE stem-loops, 
despite that ZFs usually mediate interactions between proteins and nucleic acids. The C-terminal 
part of Roquin is not as conserved, and contains a proline-rich region as well as a coiled-coil 
motif. After the ROQ domain binds to the CDE stem-loops, the C-terminal part can recruit the 
Ccr4-Caf1-Not deadenylase complex and promotes the degradation of target mRNAs (Figure 
1B) (7). The 3′-UTR of Roquin mRNA also contains a CDE, indicating that this protein is 
capable of controlling its own expression through negative feedback.  
 
Figure 2.  (A) Domain organization (upper half of the bar) and sequence conservation (lower 
half of the bar) of human Roquin. The degree of conservation is indicated in color scale. CC, 
coiled-coil. (B) Sequence alignment of the N-terminal part of Roquin and Roquin-2. Hs, Homo 
sapiens. Rn, Rattus norvegicus. Dr, Danio rerio. R1, Roquin. R2, Roquin-2. 
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A paralog of Roquin, Roquin-2 (also known as membrane-associated nucleic-acid-
binding protein, MNAB) exists in vertebrates, possibly due to gene duplication (16). The RING, 
ROQ and ZF domains of Roquin-2 are very similar to their counterparts in Roquin, while its C-
terminal part is considerably different. There is a large degree of redundancy between the 
functions of Roquin and Roquin-2, and the conditional ablation of both genes in T cells is 
required to recapitulate the phenotypes of the sanroque mouse (15, 17).  
The ROQ domain of Roquin is special in that it is a versatile RNA-binding domain 
capable of recognizing CDE stem-loops with various sequences and lengths. Furthermore, 
previous studies showed that the Roquinsan protein, which carries the M199R mutation within the 
ROQ domain, has similar affinity to CDE compared with the wild-type protein, and its structural 
integrity is also unaffected by the mutation (9). It is therefore of our interest to obtain the 
structure of the ROQ domain in complex with a CDE stem-loop to reveal the molecular basis for 
the ROQ domain′s versatility as well as the aberrant action of the Roquinsan protein.  
 
3.2 Crystal structure of the ROQ-TNF23 complex 
3.2.1 Experimental procedures 
Protein expression and purification 
Residues 89-407 of human Roquin (containing the ROQ domain) were sub-cloned into 
the pET24d vector (Novagen), and the resulting recombinant protein carried a C-terminal hexa-
His tag. E. coli BL21 Star (DE3) cells transformed with this plasmid were induced with 0.5 mM 
IPTG and grown at 37 °C for 18 h. The soluble protein was purified through nickel-agarose 
affinity (Qiagen), cation-exchange (SP Sepharose Fast Flow, GE Healthcare) and gel-filtration 
(Sephacryl S-300, GE Healthcare) chromatography. The purified protein was concentrated to 20 
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mg/ml and stored at –80 ºC in a solution containing 20 mM Tris (pH 8.5), 250 mM NaCl, 5 mM 
DTT and 5% (v/v) glycerol. The His-tag was not cleaved for crystallization.   
The selenomethionyl protein sample was produced in E. coli B834 (DE3) cells, and the 
bacteria were grown in defined LeMaster media supplemented with selenomethionine (18). The 
purification procedure was the same as that for the native protein. 
The TNF23 RNA was purchased from Integrated DNA Technologies (IDT). It was 
dissolved to 300 µM concentration, in a buffer containing 20 mM Tris (pH 8.5), 250 mM NaCl 
and 4 mM MgCl2 and the solution was heated at 98 ºC for 5 min and then slowly cooled to room 
temperature. To form the ROQ-TNF23 complex, 60 nmol of the protein and 72 nmol of the RNA 
were mixed in a solution (total volume 3 ml) containing 20 mM Tris (pH 7.9), 150 mM NaCl and 
5 mM MgCl2. The mixture was incubated on ice for 30 min prior to gel filtration 
chromatography. Fractions corresponding to the complex were collected and concentrated to 7.5 
mg/ml in a buffer containing 20 mM Tris (pH 8.5), 250 mM NaCl, 5 mM DTT and 5% (v/v) 
glycerol.   
Protein crystallization 
Crystals of the ROQ-TNF23 complex were obtained with the sitting-drop vapor-diffusion 
method at 20 ºC. The reservoir solution contained 100 mM sodium citrate (pH 5.7), 1.5 M LiCl, 
and 18-21% (w/v) PEG 6000. 1 µl of the protein-RNA complex solution at 1.5 mg/ml 
concentration (diluted with the storage buffer without glycerol) was mixed with 1 µl of the 
reservoir solution. Crystals grew to full size in one week. They belong to space group P212121, 
with unit cell parameters of a=90.8 Å, b=93.1 Å, c=100.2 Å. There are two molecules of the 
ROQ domain and a TNF23 duplex in the asymmetric unit. The crystals were cryo-protected by 
the reservoir solution supplemented to 35% (w/v) PEG 6000 and flash-frozen in liquid nitrogen. 
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Data collection and structure determination 
A single-wavelength anomalous diffraction (SAD) data set to 1.9 Å resolution was 
collected on a selenomethione-substituted crystal using an ADSC Quantum-315 CCD at 
beamline X29A of the National Synchrotron Light Source (NSLS). The diffraction data were 
processed and scaled with the HKL package (19).  
The Se atoms were located with the program SHELXD (20). The reflections were then 
phased with the program SOLVE and the phases were improved with the program RESOLVE 
(21). Most of the protein residues were automatically built by RESOLVE, and the model was 
completed by manual building with the program Coot (22). The structure refinement was 
performed using the programs CNS and Phenix (23, 24). The data processing and refinement 
statistics are summarized in Table 1.  
Table 1. Data collection and refinement statistics of the ROQ-TNF23 complex 
!
Resolution range (Å) 1 40-1.9 (2.0–1.9) 
Redundancy 3.8 (3.8) 
Rmerge (%) 6.9 (43.9) 
I/σI 19.4 (3.4) 
Number of reflections2 128,927 
Completeness (%) 100 (100) 
R factor (%) 17.7 (22.7) 
Free R factor (%) 21.2 (26.5) 
rms deviation in bond lengths (Å) 0.011 
rms deviation in bond angles (°) 1.2 
        1. The numbers in parentheses are for the highest resolution shell. 
        2. The Friedel pairs were kept as separate reflections during the refinement.  
3.2.2 Overall structure of the ROQ-TNF23 complex 
We purified the ROQ domain of human Roquin and used a 23-nt CDE RNA of the TNF-
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α gene (TNF23, Figure 3A) to reconstitute the protein-RNA complex in vitro.  The crystal 
structure of the ROQ-TNF23 complex was determined at 1.9 Å resolution using the single-
wavelength anomalous dispersion (SAD) method (Figure 3B) (25). The ROQ domain is mostly 
helical, containing 13 α-helices (αA-αM) and a three-stranded β-sheet (β1-β3). The structure 
has an elongated shape, with dimensions of approximately 25 Å × 40 Å × 75 Å, and can be 
divided into three sub-domains. Sub-domain I has six tightly packed anti-parallel helices, three 
from the N-terminal end of the ROQ domain (αA-αC) and three from the C-terminal end (αK-
αM). Sub-domain II, with four helices (αD, αH-αJ), connects the other two domains. Sub-
domain II has tight contacts with domain III, with ~900 Å2 surface area buried, whereas the 
interface with domain I is more limited (~200 Å2) and mostly hydrophilic. Sub-domain III 
encompasses residues in the middle of the ROQ domain (195-271) and contains three helices 
(αE-αG) and the three-stranded β-sheet. Unexpectedly, the backbone fold of this domain is 
similar to that of the winged-helix motif, especially the WH-B domain of the RING ubiquitin-
protein ligase cullin and related proteins (26–29). The RMSD among equivalent Cα atoms of 
domain III and the WH-B domain of cullin 1 is 2.3 Å (Figure 3C), although the sequence identity 
of the aligned residues is only 11% (30). 
There are two ROQ domains in the same asymmetric unit, and their structures are slightly 
different. Part of the three-stranded β-sheet is disordered in one structure, while the long loop 
connecting αA and αB has poor electron density in the other one (Figure 3D). Therefore, the 
complete structure of this domain can be reconstituted through combining the two molecules. 
The TNF23 binding site on the ROQ domain is an electropositive depression at the 
interface of domains I and II (Figure 3E). Only a part of the 5′ and 3′ arms of the stem directly 
contact the ROQ domain, while the loop and the flanking sequences are exposed to the solvent. 
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Figure 3. (A) Schematic drawing of the TNF23 stem-loop. The numbering scheme used in this 
chapter is also indicated. (B) Crystal structure of the ROQ-TNF23 complex at 1.9 Å resolution. 
Two views related by a 90o rotation around the vertical axis are shown. TNF23 RNA is in 
orange, while the three subdomains of the ROQ domain are colored in yellow, cyan, green, 
respectively. The side chain of the M199 residue is in stick representation, with the carbon 
atoms colored in red. Numbering of the secondary structure elements is also shown. (C) 
Overlay of the structures of domain III of ROQ domain (green) and the WH-B domain of cullin 
1 (gray). (D) Overlay of the structures of the two ROQ-TNF23 complexes in the asymmetric 
unit. The structure in color has part of the β-sheet disordered, while the αA-αB loop in the gray 
structure is disordered. The structural overlay is based on Cα atoms. (E) Electrostatic surface of 
the TNF23 binding site. Negatively charged residues are colored red while positively charged 
residues are colored blue. All the structure figures were produced with PyMOL (31). 
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3.2.3 The TNF23 RNA is a duplex in the crystal as well as in the solution 
Surprisingly, the TNF23 RNA is not in the stem-loop conformation but forms an anti-
parallel duplex in the crystal (Figure 4A). The gel-filtration profile of the sample used for 
crystallization also clearly shows that the ROQ-TNF23 complex is in the dimeric form, while the 
ROQ domain alone is a monomer in solution (Figure 4D). We speculated that the formation of 
the duplex was caused by the high concentration (300 µM) of the TNF23 RNA used for annealing 
prior to preparing the complex. In fact, the ROQ-TNF23 sample with the RNA annealed at 4.4 
µM is still predominantly dimeric if the sample is concentrated to 14 µM prior to gel-filtration 
(Figure 4D). Only under very low concentration (0.4 µM) will the TNF23 RNA adopt the stem-
loop conformation and the ROQ-TNF23 complex be monomeric (Figure 4D). Thermodynamic 
calculation shows that the free energy for the formation of the TNF23 stem-loop is merely -3.3 
kcal/mol, presumably because of the high AU-content of the stem (Figure 3A), while that for the 
duplex is -12 kcal/mol (32). Therefore, the intrinsic instability of the stem-loop conformation of 
TNF23 means that the formation of the duplex is inevitable under the concentration for the 
crystallographic study of the complex.  
The duplex contains twelve Watson-Crick base pairs formed by the nucleotides in the 
“stems” of the two TNF23 molecules (Figure 4B). The unpaired nucleotides in the “loops” have 
weaker electron density with U10 in one strand completely disordered, suggesting that this region 
is flexible (Figure 4A). A U1-G17 wobble base pair at the bottom of the stem was proposed in an 
earlier report (7), but it was not observed in the duplex. In fact, the base of U1 flips out in one 
strand and contacts the Asn349 residue of a ROQ domain in the neighboring asymmetric unit, 
while U1 of the other stand is disordered (Figures 4A, 4B).  
! 75 
 
Figure 4. (A) Composite omit electron density of the TNF23 duplex, contoured at 3σ. The red 
arrow points to the disordered U10 base in one strand. (B) Schematic drawing of the TNF23 
duplex. (C) The structure of the TNF23 duplex in complex with two ROQ domains in one 
asymmetric unit. One ROQ monomer is in color and the other in gray. There is no contact 
between the ROQ domain and the nucleotides in the center of the duplex, which correspond to 
the loop in the stem-loop conformation. (D) Gel-filtration profiles the ROQ-TNF23 complexes 
prepared under different conditions. The absorption of UV at 260 nM wavelength is plotted. 
The gray dashed lines indicate the elution volumes of the ROQ domain and the dimeric ROQ-
TNF23 complex, respectively. The ROQ-TNF23 complex in the bottom panel is primarily in the 
monomeric form. 
3.2.4 The TNF23 binding site is not sequence specific and has moderate plasticity 
Both arms of the base-paired region of the TNF23 duplex interact with the ROQ domain 
(Figure 5A). Nucleotides U4, U5 and U6 in the 5′ arm are hydrogen-bonded to residues Ser315, 
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Gln318, Ser319, Asp322 and Lys323 from helix αJ in the C-terminal part of domain II (Figure 
5B). On the other side, nucleotides A14, A15 and C16 near the end of the 3′ arm contact Arg135 
and Lys136 in αB, as well as Ser160 and Arg164 in αC in domain I (Figure 5C). Several water 
molecules also mediate the protein-RNA interactions. The ROQ domain does not recognize the 
exact sequence of the TNF23 RNA, although one of the hydrogen bonds between Gln318 and U4 
requires the carbonyl oxygen on the C2 atom of a pyrimidine base. It appears that neither arm of 
the base-paired region has strong interactions with the ROQ domain. Therefore, binding to both 
arms should be required for high affinity association with the ROQ domain. In fact, the ROQ 
domain does not interact with single-stranded RNAs (section 3.4.4).  
Although the TNF23 binding surfaces on the two ROQ domains in the same asymmetric 
unit have almost identical structures, there are considerable differences in the conformation as 
well as the bound position of the RNA between the two complexes, especially near the ends of 
the duplex (Figures 5D). In the complex where U1 flips out, the preceding A–1 nucleotide in the 
5′ flanking sequence base-stacks against G2 and forms a non-Watson-Crick base pair with G17. 
The 3′ flanking nucleotides G+1 and A+2 are ordered, and G+1 forms bidentate hydrogen bonds 
with the side-chain guanidinium group of Arg131 (αB), which also π-stacks against the bases of 
G17 and A+2  (Figure 5E). In the other complex, A–1, U1 and A+2 are disordered. Moreover, the 
position of the guanine base of G17 is substantially shifted compared to the other complex. As a 
result, Arg131 interacts with G17 instead of G+1 through the bidentate hydrogen bonds (Figure 
5F).  The differences indicate that there is conformational flexibility in the RNA itself and 
plasticity in its interaction with the ROQ domain. 
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Figure 5. (A) Overview the TNF23 binding site. Only the ROQ-TNF23 complex where the U1 
base flips out is shown here. (B) Interactions between the 5′ arm of TNF23 and subdomain II of 
the ROQ domain. Hydrogen bonds are indicated as red dashed lines. Water molecules are 
shown as red spheres. (C) Interactions between the 3′ arm of TNF23 and subdomain I of the 
ROQ domain. (D) Overlay of the two halves of the TNF23 duplex. The part of the duplex where 
U1 flips out is in orange, while the other part is in gray. (E) Interactions of Arg131 with 
nucleotides near the end of the duplex in the ROQ-TNF23 complex where U1 flips out. (F) 
Interactions of Arg131 with the G17 base in the ROQ-TNF23 complex (gray) where U1 and A–1 
are disordered. The G17 base from the other complex is also shown (in orange). The red arrow 
indicates the change in the position of this base in the two complexes. 
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3.3 Crystal structure of the ROQ-Hmg19 complex 
3.3.1 Experimental procedures 
Protein expression and purification 
The ROQ domain was expressed and purified with the same protocol as in 3.2.1. The 
Hmg19 RNA was purchased from IDT. It was diluted to 40 µM concentration and annealed in the 
same manner as TNF23. The ROQ-Hmg19 complex was assembled and purified in a similar way 
to the ROQ-TNF23 complex. 13 nmol of the protein and 15 nmol of the RNA were mixed in total 
volume of 1.5 ml, and the fractions from gel-filtration were concentrated to 6.4 mg/ml.  
Protein crystallization 
Crystals of the ROQ-Hmg19 complex were obtained with the hanging-drop vapor-
diffusion method at 20 ºC. The reservoir solution contained 100 mM Tris (pH 8.2), 0.3 M 
calcium acetate and 12-14% (w/v) PEG 8000. 1 µl of the protein-RNA complex solution at 3 
mg/ml concentration was mixed with 1 µl of the reservoir solution. Crystals grew to full size in 
two weeks. They belong to space group P21, with unit cell parameters of a=49.6 Å, b=170.0 Å, 
c=51.1 Å, and β=97.0°. There are two copies of the ROQ-Hmg19 complex in the asymmetric 
unit. The crystals were cryo-protected by the reservoir solution supplemented to 35% (w/v) PEG 
8000 and flash-frozen in liquid nitrogen for data collection at 100K. 
Data collection and structure determination 
A native data set to 2.9 Å resolution on the ROQ-Hmg19 complex was collected at the 
X25 beamline of the NSLS, on a Pilatus 6M detector. The structure was determined by the 
molecular replacement method, with the program COMO (33). The three subdomains of the 
ROQ domain were searched independently in the calculation. The structure refinement was 
performed using the programs Phenix (24). The data processing and refinement statistics are 
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summarized in Table 2.  
Table 2. Data collection and refinement statistics of the ROQ-Hmg19 complex 
!
Resolution range (Å) 1 40-2.9 (3.0–2.9) 
Redundancy 2.1 (1.9) 
Rmerge (%) 9.4 (41.5) 
I/σI 9.1 (1.7) 
Number of reflections 17,984 
Completeness (%) 97 (88) 
R factor (%) 19.5 (29.1) 
Free R factor (%) 25.1 (37.3) 
rms deviation in bond lengths (Å) 0.010 
rms deviation in bond angles (°) 1.4 
        1. The numbers in parentheses are for the highest resolution shell. 
3.3.2 Hmg19 binds to a different site on the ROQ domain 
Uncertain that the binding mode of the TNF23 duplex represents the molecular basis for 
the recognition of CDE stem-loops by the ROQ domain, we obtained a 19-nt CDE RNA of the 
Hmgxb3 gene and named it Hmg19 in our studies (Figure 6A). Hmg19 has a GC-rich stem and the 
free energy for stem-loop formation is -7.7 kcal/mol, substantially more thermodynamically 
favorable than that of TNF23. We determined the crystal structure of the ROQ-Hmg19 complex at 
2.9 Å resolution and confirmed that the RNA is in the stem-loop conformation based on its 
electron density (Figure 6B). Unexpectedly, Hmg19 binds to a surface on the ROQ domain that is 
opposite to the TNF23 binding site (Figure 6C). The Hmg19 binding site is mostly comprised of 
the WH motif of domain III (αF, αG, β2, β3), and the N-terminal part of domain II (αD) also 
participates in the recognition of Hmg19. For convenience, we designate the Hmg19 binding site 




Figure 6. (A) Schematic drawing of the Hmg19 RNA stem-loop. The numbering scheme used in 
this chapter is also indicated. (B) Composite omit electron density map of the Hmg19 RNA, 
contoured at 3σ level. (C) Crystal structure of the ROQ-Hmg19 complex at 2.9 Å resolution. 
Two views related by a 90o rotation around the vertical axis are shown. Hmg19 RNA is in 
orange. The side chain of the M199 residue is in stick representation, with the carbon atoms 
colored in red.  
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Apart from the distinct binding site, the recognition mode of Hmg19 is also in stark 
contrast to that of TNF23. The Hmg19 stem-loop RNA primarily interacts with the ROQ domain 
through the 3-nt loop and the 5′ arm of the stem, with the 3′ arm having few contacts with the 
protein and weaker electron density (Figure 6B). Both pyrimidine bases in the U8G9U10 triloop 
flip out and have close contacts with domain III (Figure 7A). The U8 base lies against the β-turn 
connecting strands β2 and β3 in the β-sheet (the “wing”) of the WH motif and is π-stacked with 
the peptide bond between residues Asp263 and Ser264. The backbone phosphate group of U8 is 
located near the N-terminus of helix αF, having favorable interactions with the dipole of this 
helix. The U10 base lies against the C-terminal end of helix αG and is hydrogen-bonded to the 
side chain of Ser253. The G9 base is stacked with the C7-G11 base pair at the top of the stem on 
one face, and the guanidinium group of Arg219 (αF) on the other. The base and the phosphate 
group of G9 also form hydrogen bonds with the side chains of Gln247 and Tyr250 (both in αG), 
respectively. The phosphate group of G11 at the top of the 3′ arm of the stem interacts with the 
side chain of Arg251 (αG) (Figure. 7A), representing the only direct contact between the A site 
and the 3′ arm of the stem. In the 5′ arm of the stem, the phosphate groups of nucleotides C4 to 
C7 have hydrogen bond and ionic interactions with residues Lys220, Ser238, Lys239, Thr240 
and Arg251 in helices αF and αG of domain III (Figures 7A, 7B). Moreover, the phosphate 
groups of C2 and C3 are near the side chain of Arg188 in helix αD of domain II, while the indole 
ring of Trp184 in the same helix is π-stacked with the base of U1, which is flipped ~180° from 
the helical pattern of the stem (Figure 7B).  
Of all the nucleotides in Hmg19, only G9 is somewhat specifically recognized by the ROQ 
domain. The π-stacking and especially its hydrogen-bonding with Gln247 may select for a purine 
over pyrimidines, explaining the fact that all the CDEs identified so far have a purine at this 
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position of the loop (7). Interactions between the ROQ domain and the rest of the stem-loop 
predominantly involve the backbone phosphate groups and show little sequence specificity.  
The structure of the A site provides no mechanism to restrict the length of the stem, 
consistent with the variable sizes of the CDE stem-loops (Figure 1). Nonetheless, this site has 
intricate interactions with the loop and recognizes its shape. This provides a degree of specificity 
in the interactions between the ROQ domain and Hmg19, explaining the presence of the triloop in 
all known CDEs. 
Hmg19 is bound to an electropositive surface patch primarily on the winged-helix (WH) 
motif of domain III (Figure 7C). Therefore, even if the side chains of several basic residues 
(Arg188, Lys220 and Lys239) interacting with the 5′ arm of Hmg19 have weak electron density, 
they contribute to the electrostatic properties of this surface. This surface is also present in other 
WH motifs and mediates the binding of nucleic acids. One example is the WH motif of the 
translation elongation factor SelB which interacts with the SECIS mRNA hairpin (Figure 7D) 
(34). However, the binding modes of these nucleic acids are rather different from that of Hmg19.  
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Figure 7. (A) Interactions between the triloop of Hmg19 and the ROQ domain. Red dashed lines 
indicate hydrogen bonds. (B) Interactions between the 5′ arm of Hmg19 and the ROQ domain. 
(C) Electrostatic surface of the Hmg19 binding site. Negatively charged residues are colored red 
while positively charged residues are colored blue. (D) Overlay of the structures of domain III 
of ROQ domain (green) and the WH motif of elongation factor SelB in complex with SECIS 
RNA (gray). 
3.3.3 Comparison of the structures of the two complexes 
In addition to the distinct RNA binding sites and recognition modes, differences in the 
structures of the ROQ domain in the ROQ-TNF23 and ROQ-Hmg19 complexes were also 
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observed. In the ROQ-TNF23 complex, the B site at the interface between domains I and II is 
widely open to make room for the TNF23 duplex. In comparison, domain I is rotated by ~30o 
towards domain II in the ROQ-Hmg19 complex, thus closing up the B site and making it 
impossible to accommodate the TNF23 duplex due to steric clashes (Figure 8A). Domains II and 
III, however, are almost identical in the two complexes except for slight differences at the β2-β3 
loop in the “wing” of domain III, which probably results from Hmg19 binding. Provided that the 
interface buried between domains II and III (900 Å2) is much more extensive than that between 
domains I and II (200 Å2), we postulate that in solution, domains II and III are likely to form a 
compact unit while domain I may be flexible in the absence of RNA. The binding of the TNF23 
duplex can somewhat immobilize domain I and maintain the open conformation of the B site. 
Intriguingly, helices αH-αJ in the C-terminal part of domain II that contact the TNF23 
duplex form a helix-turn-helix (HTH) motif and show similarities to helices αE-αG in the WH 
motif of domain III which recognize Hmg19 (Figure 8B). The RMSD is 2.1 Å for 44 equivalent 
Cα atoms, and the sequence conservation is 16% (30). The two domains also use the equivalent 
surface area (αJ in domain II, αG in domain III) to interact with the RNAs. Nevertheless, the 
orientations of the RNAs at the two sites are sharply different, with their axes almost 90 degrees 
away from each other (Figure 8B). It should be noted, however, that the conformations of Hmg19 
and TNF23 bound to the ROQ domain are very similar, especially between the stem of Hmg19 
and the base-paired region of the TNF23 duplex, both being very similar to classical A-form 






Table 3. Helical parameters of the base-paired regions of the TNF23 duplex (35) 
 
Base pair step 
X-disp (Å) Incline (°) Rise (Å) Twist (°) 
Ia IIa I II I II I II 
G2C16 → U3A15 -3.90 -3.73 6.26 2.72 3.18 3.05 32.86 30.15 
U3A15 → U4A14 -3.44 -3.14 7.72 8.89 2.79 2.95 31.14 33.21 
U4A14 → U5A13 -4.21 -4.05 6.27 16.61 3.09 2.73 31.53 34.19 
U5A13 → U6A12 -4.85 -2.81 14.54 10.26 2.73 2.77 29.77 33.10 
U6A12 → C7G11 -2.94 -3.57 8.77 6.32 2.84 3.23 32.97 33.97 
Average -3.87 -3.46 8.71 8.96 2.93 2.94 31.65 32.93 
Classical A-form RNA -4.0 15.3 2.8 33.0 




Table 4. Helical parameters of the stem of Hmg19 
 
Base pair step 
X-disp (Å) Incline (°) Rise (Å) Twist (°) 
I I I I 
C2G16 → C3G15 -3.36 5.59 3.0 34.04 
C3G15 → C4G14 -4.31 7.79 3.08 31.91 
C4G14 → U5A13 -5.66 11.45 2.58 27.29 
U5A13 → U6A12 -2.98 5.00 2.82 37.24 
U6A12 → C7G11 -4.62 17.82 2.33 31.29 
Average -4.19 9.53 2.77 32.35 




Figure 8.   (A) Overlay of the structures of the ROQ-Hmg19 complex (color) and the ROQ-
TNF23 complex (gray). The 30o rotation of domain I relative to domains II and III is shown. The 
red square circles the β2-β3 loop in domain III that are shifted slightly between the two 
structures. (B) Overlay of the structures of domain III (green) in complex with Hmg19 (orange) 
and domain II (cyan) in complex with TNF23 (yellow). Helix αD of domain II is not shown 
here. Only the backbones of the RNA molecules are shown. (C) Overlay of the structures of 
Hmg19 (orange) and TNF23 (black) in the two complexes. Only the half of the TNF23 duplex 
where U1 flips out is shown here. 
3.3.4 The Met199 residue does not directly interact with either RNA 
The Met199 residue is located near the N-terminus of αE in domain III and is far away 
from the TNF23 duplex at the B site (Figure 3B). Moreover, the shortest distance between 
Met199 and the Hmg19 RNA is 10 Å, meaning that there is no direct interaction between them 
(Figure 9A). This is in agreement with previous reports that the Roquinsan protein (M199R 
mutant) has similar affinity towards CDE stem-loops compared with the wild-type protein (7).  
The side-chain of Met199 is partially exposed to the solvent (Figure 9B) and has hydrophobic 
interactions with Leu195 and Phe234 (Figure 9A). It is unlikely that the M199R mutation could 
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severely disrupt the structure of the ROQ domain, which is supported by the result that there is 
little difference between the endogenous expression levels of the wild-type Roquin and Roquinsan 
proteins (9). In addition to recognizing nucleic acids, WH motifs have also been shown to 
mediate protein-protein interactions (28, 36). Therefore, it is likely that the M199R mutation 
causes the sanroque phenotype via a different mechanism, for example disrupting interactions 
with a protein partner as an Arg side chain would change the shape and electrostatic properties of 
that region on the surface of domain III. 
 
Figure 9.   (A) Structure of the ROQ-Hmg19 complex in the neighborhood of the Met199 
residue. The red dashed line shows the shortest distance between Met199 and the Hmg19 RNA. 
(B) Surface representation of domain III in the view of Figure 9A. The red and yellow patches 
represent the solvent-accessible surface of the side chain of Met199.  
 
3.4 Biochemical studies of the ROQ-RNA complexes with EMSA 
3.4.1 Experimental procedures 
Mutagenesis of the ROQ domain 
The ROQ domain mutants were made with the QuikChange kit (Stratagene) and verified 
through sequencing. The mutant proteins were purified by nickel affinity and cation exchange 
chromatography.  
Electrophoretic mobility shift assay (EMSA) 
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The Hmg19, TNF23 and TNFds RNAs with 6-FAM fluorescent label at the 5′-end were 
purchased from IDT. The RNAs were diluted to 5 µM and heated at 98 °C for 5 min and then 
slow-cooled to room temperature. The protein-RNA mixtures were prepared in a buffer 
containing 20 mM Tris (pH 8.2), 5 mM MgCl2, and 50 or 200 mM NaCl. The samples were 
loaded to 0.8% native agarose gel. The electrophoresis was performed in 1× TAE buffer (pH 8.0) 
at 4 °C, and then the RNA bands were visualized on a UV illuminator. 
3.4.2 Mutations at the A or B site abolish stem-loop or dsRNA binding respectively 
We revealed two distinct RNA binding sites in the ROQ domain through the crystal 
structures of the ROQ-Hmg19 and ROQ-TNF23 complexes. The A site is primarily located on 
domain III and interacts with the Hmg19 stem-loop RNA, while the B site is a surface cleft at the 
interface between sub-domains I and II and interacts with the TNF23 duplex. We mutated several 
residues that are important for RNA binding at the A or B site based on the structures, and used 
EMSA to evaluate their effects on the binding of different RNAs. Three different RNA 
molecules were used in the assays, all carrying a 5′ 6-FAM fluorescent label. The labeled Hmg19 
and TNF23 RNAs are the same as those used for crystallographic studies. We also constructed the 
double-stranded TNFds RNA by replacing the tri-loop of TNF23 with two GC base pairs at the top 
of the stem (Figure 10A). Under the concentration (1 µM) for EMSA, both Hmg19 and TNF23 
should largely adopt the stem-loop conformation.  
We first did EMSA with 200 mM NaCl in the buffer. The A site mutants cannot bind to 
either Hmg19 or TNF23, while the B site mutants interact with these stem-loop RNAs as strongly 
as WT ROQ (Figure 10B, top two panels). The ROQ domain’s affinity to TNFds is low under the 
same condition, and we could not observe clear bands even for WT ROQ, indicating that the 
protein-RNA complexes had disassociated in the gel (Figure 10B, bottom panel). To improve the 
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ROQ-TNFds interaction, we performed the same assay with 50 mM NaCl in the buffer. The 
results clearly showed that the B site mutants abolish the ROQ domain’s interaction with TNFds, 
while no difference in binding is observed for the A site mutants (Figure 10C, bottom panel). It 
should be noted, however, that the differences in the affinity to the stem-loop RNAs between 
WT ROQ and the A site mutants are less obvious under such low ionic strength (Figure 10C, top 
two panels).  
 
Figure 10.   (A) Schematic drawing of the RNAs used for EMSAs. (B) EMSA with the WT and 
the mutant ROQ proteins under 200 mM NaCl. The slow-moving bands that represent the 
protein-RNA complexes run at different rates on the gel due to the altered electrostatic 
properties of the complexes caused by the mutations. (C) EMSA with the WT and the mutant 
ROQ proteins under 50 mM NaCl. The RNAs and proteins in all of the samples were under 1 
µM concentration.  
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The EMSA results prove that the A site recognizes stem-loop RNAs while the B site 
binds to double-stranded RNAs. The protein-RNA interactions are weakened by higher ionic 
strength, which is supported by the hydrophilic nature of the interfaces. Moreover, the A site 
seems to have higher affinity compared to the B site, consistent with the more extensive protein-
RNA interface at the A site (915 Å2) than the B site (475 Å2).  
3.4.3 The two distinct RNA binding sites are independent of each other 
We next attempted to explore whether the two distinct RNA binding sites are 
independent or allosterically correlated. We pre-incubated the WT ROQ domain with labeled 
TNFds RNA, and unlabeled Hmg19 RNA was added later. A faster-moving band was observed on 
the gel, indicating the formation of the ROQ-TNFds-Hmg19 ternary complex (Figure 11A). In 
contrast, an A site mutant (Q247A/Y250A/R251E) can only form the binary complex with TNFds 
(Figure 11B). Similar results were obtained through pre-incubating the ROQ domain with Hmg19 
and adding TNFds subsequently. We thus conclude that the A and B sites are mostly independent 
of each other, and the stem-loop and double-stranded RNAs can bind to the ROQ domain either 
individually (as observed in the crystal structures) or simultaneously.  
We noticed that the A site mutant (Q247A/Y250A/R251E) with TNFds bound could not 
interact with Hmg19 at all, even if the low ionic strength (50 mM NaCl) in the samples permits 
the mutant to form weak binary complexes with the stem-loop RNAs (Figure 10C, top two 
panels). One possible explanation is that the binding of TNFds at the B site causes the overall 
electrostatic property of the ROQ domain to be less favorable for RNA binding, lowering the 
affinity at the A site. Although such a subtle change may have little noticeable effect on the WT 




Figure 11.   (A) EMSA with WT ROQ, labeled TNF23, and unlabeled Hmg19. The 
concentrations of each molecule in each sample are indicated. (B) EMSA with an A site ROQ 
mutant, labeled TNF23, and unlabeled Hmg19. All the EMSA samples were mixed in a buffer 
containing 50 mM NaCl.  
3.4.4 The B site only recognizes double-stranded RNAs 
As the A site of the ROQ domain has extensive interactions with the triloop of Hmg19, it 
is unlikely to accommodate double-stranded RNAs. The B site, on the other hand, mostly 
interacts with the base-paired region of the TNF23 duplex, leaving the unpaired region (the 
“loop”) as well as the flanking sequences exposed to solvent. In addition, the shape of the stem 
of Hmg19 is highly similar to the base-paired region of the TNF23 duplex (Figure 8C). Therefore, 
we hypothesized that the B site may recognize both double-stranded and stem-loop RNAs. 
To test this hypothesis, we performed EMSA with WT ROQ and the stem-loop RNAs 
with elevated RNA:protein ratios to as high as 6:1. If the B site indeed recognizes the stem of the 
SL RNAs, faster-moving bands representing the ROQ-SL RNA (1:2) complex should appear. 
Nonetheless, neither Hmg19 nor TNF23 could form the 1:2 complexes with WT ROQ (Figure 
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12A). One possible reason for the failure of the B site to accommodate Hmg19 or TNF23 is their 
shorter stems compared to the 12-bp TNF23 duplex as well as the 8-bp TNFds RNA. We thereby 
extended the stem of Hmg19 to 9 base pairs or 12 base pairs (Figure 12B). The results showed 
that the A site can interact with the longer stem-loop RNAs, yet the B site still fails to recognize 
them (Figure 12C). In order to minimize the negative influence the stem-loop RNA bound to the 
A site would exert on the B site, we replaced WT ROQ with an A site mutant 
(Q247A/Y250A/R251E). It nonetheless behaves similarly to the wild-type protein (Figure 12D). 
Finally, we proved that the B site does not recognize single-stranded RNA or double-stranded 
DNA molecules either (Figures 12E, 12F).  
Therefore, based on the crystal structures and the EMSA results, we can draw several 
conclusions regarding the specificity of the two distinct RNA binding sites. The A site interacts 
with stem-loop RNAs and shows little preference for the length and the sequence of the stem. It 
however may favor stem-loop RNAs containing three nucleotides in the loop with a purine in the 
middle. The RNA binding mode of the A site hence is consistent with the recognition pattern of 
the CDE stem-loops by Roquin. On the other hand, the B site only interacts with double-stranded 
RNAs and has minimal sequence specificity. Our current structural and biochemical data cannot 
explain why the B site is incapable of recognizing stem-loop RNAs. Moreover, the biological 
significance of the B site remains to be characterized. 
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Figure 12. (A) EMSA with the Hmg19 or TNF23 stem-loop RNAs and decreasing amount of WT 
ROQ. Only bands representing the ROQ-RNA (1:1) complexes are present. (B) Schematic 
drawing of the longer stem-loop RNAs. (C) EMSA with the longer stem-loop RNAs and 
decreasing amount of WT ROQ. (D) EMSA with an A site mutant of ROQ and increasing 
amount of the longer stem-loop RNAs. The slow-moving faint bands represent the weak ROQ-
RNA complexes mediated by the A site. (E) EMSA with the 5′ arm of TNFds and WT ROQ. (F) 
EMSA with a double-stranded DNA molecule and the WT and mutant ROQ proteins. The DNA 
bands were visualized by ethidium bromide instead of fluorescent labels. All the samples for the 
EMSA were incubated in a buffer containing 50 mM NaCl.  
 
3.5 Discussion and future directions 
We identified two distinct RNA-binding sites in the ROQ domain of Roquin. The A site 
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interacts with stem-loop RNAs while the B site binds to double-stranded RNAs. We have good 
evidence that the ROQ domain uses the A site to recognize the CDE stem-loops. This conclusion 
can be further proved through ex vivo mRNA decay assays using WT Roquin and the A site 
mutants (currently being performed by the Megerditch Kiledjian group). We are also interested 
in the systemic phenotypes the A site mutants may cause in the mammalian immune system.  
3.5.1 Possible functions of the B site 
The biggest mystery in our studies on the ROQ domain of Roquin is the biological 
significance of the B site. It is possible that the double-stranded RNA bound to the B site is also 
part of the CDE. Based on the crystal structures of the ROQ-Hmg19 and ROQ-TNF23 complexes, 
the 5′ end of Hmg19 can be connected to the TNF23 duplex by a 7-nt linker, while the linker 
between TNF23 and the 3′ end Hmg19 needs to be longer (Figure 13A). The A and B sites on the 
ROQ domain thus may synergistically recognize the two segments of the CDE (Figure 13B), 
leading to higher affinity and specificity. Nevertheless, although all known CDEs are predicted 
to include the stem-loop structure, no consensus double-stranded element near the stem-loop can 
be found. Besides, this hypothesis can also be negated if the B site mutants can destabilize the 
target mRNAs to the same extent as the WT protein in the ex vivo mRNA decay assays.  
Another possible function of the B site is to recognize double-stranded mRNA elements 
other than the CDEs. Sequencing the mRNAs pulled-down by WT ROQ identified 95 genes that 
were enriched by at least 8-fold in the ROQ-IP compared to the control-IP (7). Despite that most 
of the CDE-containing mRNAs were co-precipitated with Roquin, the majority of the genes on 
the list are predicted to have no CDE-like structures. Some of these genes, such as Irf4 and Id1, 
are also important modulators of immune responses (37, 38). Others such as Slc39a4 and 
Adamts1, nonetheless participate in a variety of pathways including iron-uptake, bone 
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development, tumor growth, etc. (39–41). This is in agreement with earlier reports showing 
Roquin’s important roles in processes other than regulating the expression of immune regulators 
(11–13). Therefore, we hypothesize that Roquin recognizes and controls the expression of the 
CDE-less mRNAs through the B site. This hypothesis can be tested by performing mRNA pull-
down assays with WT ROQ as well as the A site mutants. mRNAs that are highly enriched in the 
A site mutant pull-down compared to the WT pull-down are probable targets of the B site. These 
potential targets can then be corroborated through ex vivo mRNA decay assays.  
 
Figure 13. (A) Possible linkages between the RNA molecules in the B site and A site. A single-
stranded RNA (gray, 7 nts) was modeled to connect the 3′-end of the RNA in the B site to the 5′ 
end of the stem-loop RNA in the A site (~30 Å distance). A linker between the 3′ end of the 
RNA in the A site to the 5′ end of the RNA in the B site would need to span ~60 Å (gray dots). 
(B) Schematic drawing of the model in (A).  
3.5.2 A model explaining the specificity of the B site 
The second problem with the B site is the underlying mechanism for its preference for 
double-stranded RNAs against stem-loop RNAs. Our structural studies suggest that the degree of 
openness of the B site may vary in solution due to the flexibility of domain I. TNF23 bound to the 
B site nonetheless immobilizes domain I and maintains the widely open conformation. 
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Therefore, RNAs to be recognized by the B site probably need to overcome a free energy barrier 
resulting from the conformational changes in the ROQ domain. We hence propose a model for 
the binding of double-stranded RNAs to the B site (Figure 14). The RNA approaches the B site 
in a manner that the axis of the duplex is parallel to that of the would-be RNA binding channel, 
which is mostly closed at the unbound state. The RNA subsequently contacts one end of the 
binding-channel and induces it to open up, which is followed by the duplex “inserting” further 
into the channel until it reaches the final bound position. At the intermediate stage, the loss of 
entropy caused by the opening-up of the channel and the immobilization of domain I could be 
compensated by the enthalpy gains from the transient protein-RNA interactions. The loop of a 
stem-loop RNA will likely clash with the protein residues lining the channel and prevent the 
RNA from further inserting into the B site. 
 
Figure 14. A model for the binding of double-stranded RNAs to the B site. Two views of the 
ROQ domain are shown here. The coloring scheme is the same as Figure 3. 
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No evidence is available to test the validity of this “insertion model”. Molecular 
dynamics (MD) simulation of the ROQ-dsRNA complex will probably provide some clues, yet 
this effort is likely to be hampered by the limitations of the current force fields which cannot 
satisfactorily simulate nucleic acid molecules.  
3.5.3 Identification of proteins that interact with the ROQ domain 
As stated in section 3.3.4, the M199R mutant of Roquin interacts with the CDE stem-
loops as strongly as the WT protein, while its failure of promoting mRNA decay is probably 
attributable to disrupted protein-protein interactions. Mass spectrometry has identified many 
proteins that are pulled-down by endogenous full-length Roquin, including some subunits of the 
Ccr4-Caf1-Not deadenylase complex (7). However, this study failed to distinguish direct 
contacts from RNA-mediated interactions. In order to identify the proteins whose interactions 
with the ROQ domain are directly disrupted by the M199R mutation, we should first treat the 
cell extract with nucleases, and then perform the immunoprecipitation assays using tagged WT 
ROQ domain or the M199R mutant. The binding partners that are enriched by WT ROQ relative 
to the M199R mutant are the potential targets, which can be further corroborated through 
biochemical assays such as gel-filtration, yeast two-hybrid, etc.  
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